| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 CHSY1 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.76e-11 | 35 | 290 | 10 | GO:0015020 |
| GeneOntologyMolecularFunction | retinoic acid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.38e-10 | 28 | 290 | 9 | GO:0001972 |
| GeneOntologyMolecularFunction | retinoid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.59e-08 | 48 | 290 | 9 | GO:0005501 |
| GeneOntologyMolecularFunction | isoprenoid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.14e-08 | 49 | 290 | 9 | GO:0019840 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | B3GALT1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 CHSY1 UGT1A9 UGT1A4 UGT1A1 UGT1A3 WDFY3 GALNT5 | 3.82e-07 | 153 | 290 | 13 | GO:0008194 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | B3GALT1 GBE1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 CHSY1 UGT1A9 UGT1A4 UGT1A1 UGT1A3 WDFY3 GALNT5 | 2.70e-06 | 211 | 290 | 14 | GO:0016758 |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 TMEM175 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.63e-06 | 107 | 290 | 10 | GO:0033293 |
| GeneOntologyMolecularFunction | lipid binding | STARD8 SNX16 NR4A1 CEACAM1 ITPR3 GRAMD1B DLC1 BTK OSBPL1A MME DNM1 ARAP1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 DOK7 GRAMD1A ATG2B TMEM175 UGT1A9 CERT1 UGT1A4 UGT1A1 UGT1A3 P2RX2 RACGAP1 WDFY3 GRAMD1C RUBCN PRLR ADAP2 | 7.62e-06 | 988 | 290 | 33 | GO:0008289 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | B3GALT1 GBE1 ST8SIA4 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 CHSY1 UGT1A9 UGT1A4 UGT1A1 UGT1A3 WDFY3 GALNT5 | 2.22e-05 | 288 | 290 | 15 | GO:0016757 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 8.93e-05 | 17 | 290 | 4 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 8.93e-05 | 17 | 290 | 4 | GO:0019198 | |
| GeneOntologyMolecularFunction | organic acid binding | ST8SIA4 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 TMEM175 UGT1A9 UGT1A4 UGT1A1 UGT1A3 CD22 P2RX2 | 9.33e-05 | 254 | 290 | 13 | GO:0043177 |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 1.02e-04 | 7 | 290 | 3 | GO:0005004 | |
| GeneOntologyMolecularFunction | steroid binding | GRAMD1B OSBPL1A UGT1A10 UGT1A8 UGT1A7 GRAMD1A UGT1A9 UGT1A1 GRAMD1C | 1.44e-04 | 133 | 290 | 9 | GO:0005496 |
| GeneOntologyMolecularFunction | carboxylic acid binding | ST8SIA4 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 TMEM175 UGT1A9 UGT1A4 UGT1A1 UGT1A3 CD22 | 2.06e-04 | 239 | 290 | 12 | GO:0031406 |
| GeneOntologyMolecularFunction | betaine-homocysteine S-methyltransferase activity | 2.10e-04 | 2 | 290 | 2 | GO:0047150 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | SNX16 CEACAM1 ITPR3 BTK DNM1 ARAP1 DOK7 ATG2B CERT1 P2RX2 RACGAP1 WDFY3 RUBCN ADAP2 | 2.30e-04 | 316 | 290 | 14 | GO:0035091 |
| GeneOntologyMolecularFunction | endopeptidase activity | MEP1B ATG4B PARL ADAMTS15 C1R MME MMP11 MMP14 KLK1 USP30 CAPN2 ACE2 GZMM YME1L1 CTSL TMPRSS11A | 5.89e-04 | 430 | 290 | 16 | GO:0004175 |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 6.25e-04 | 3 | 290 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 7.06e-04 | 49 | 290 | 5 | GO:0005547 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 1.21e-03 | 15 | 290 | 3 | GO:0005005 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.81e-12 | 21 | 290 | 9 | GO:0052695 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.81e-11 | 26 | 290 | 9 | GO:0019585 |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.81e-11 | 26 | 290 | 9 | GO:0006063 |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 5.31e-10 | 5 | 290 | 5 | GO:0052696 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 3.15e-09 | 6 | 290 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.16e-08 | 13 | 290 | 6 | GO:0009812 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.89e-07 | 5 | 290 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 3.88e-07 | 12 | 290 | 5 | GO:0052697 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 5.62e-07 | 6 | 290 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 5.62e-07 | 6 | 290 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | LILRB2 CDKL3 CHEK1 LRRTM1 TTC3 ABCA7 NRP1 SEMA3A SPTBN5 DLC1 PTPRG PTPRO PARL MINAR1 IQCJ-SCHIP1 SCFD1 MMP14 ARAP1 ANKRD13D USP30 BMERB1 SHANK3 ACTR3 RLF EFNB2 CST1 LRP1 MPHOSPH9 RUBCN TOP2A EPHA3 EPHA4 | 6.21e-07 | 864 | 290 | 32 | GO:0051129 |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | CDKL3 TTC3 NRP1 SEMA3A PTPRG PTPRO MINAR1 ACTR3 EFNB2 LRP1 EPHA3 EPHA4 | 5.08e-06 | 169 | 290 | 12 | GO:0010977 |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 7.52e-06 | 10 | 290 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 7.52e-06 | 10 | 290 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 8.98e-06 | 21 | 290 | 5 | GO:0042447 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ILK CARMIL3 LILRB2 TMEM135 CHEK1 LRRTM1 BCL7A NRP1 SPTBN5 DLC1 ANAPC1 RAB3GAP2 CLTC PARL PISD IQCJ-SCHIP1 SCFD1 WDR1 ARAP1 USP30 SYNE1 CAPN2 BMERB1 TBC1D25 SHANK3 ACTR3 PPP1R10 XIRP2 LRP1 LRP5 KIRREL1 MPHOSPH9 RIOK2 YME1L1 CNOT1 RUBCN TOP2A EPHA3 EPHA5 | 1.32e-05 | 1342 | 290 | 39 | GO:0033043 |
| GeneOntologyBiologicalProcess | cell junction organization | CARMIL3 LILRB2 LRRTM1 CEACAM1 NRP1 SEMA3A ZDHHC15 DLC1 PTPRO FLRT2 WDR1 MMP14 SDK1 NPTX1 SDK2 SORBS2 DOK7 SORBS1 SHANK3 ACTR3 ACE2 EFNB2 XIRP2 P2RX2 LRP1 LRP5 KIRREL1 CDH18 EPHA3 EPHA4 EPHA5 | 2.00e-05 | 974 | 290 | 31 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | CDKL3 TTC3 NRP1 SEMA3A PTPRG PTPRO MINAR1 ACTR3 EFNB2 LRP1 MPHOSPH9 EPHA3 EPHA4 | 2.78e-05 | 233 | 290 | 13 | GO:0031345 |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 3.65e-05 | 89 | 290 | 8 | GO:0001523 | |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 4.00e-05 | 28 | 290 | 5 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 4.00e-05 | 28 | 290 | 5 | GO:0007413 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle acetylcholine-gated channel clustering | 4.62e-05 | 15 | 290 | 4 | GO:1904393 | |
| GeneOntologyBiologicalProcess | regulation of receptor clustering | 4.78e-05 | 29 | 290 | 5 | GO:1903909 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 5.42e-05 | 94 | 290 | 8 | GO:0016101 | |
| GeneOntologyBiologicalProcess | protein processing | MAGEA3 ATG4B PARL C1R PISD MME MMP14 KLK1 CAPN2 ACE2 C2CD3 CUZD1 YME1L1 CTSL | 5.57e-05 | 285 | 290 | 14 | GO:0016485 |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 8.67e-05 | 52 | 290 | 6 | GO:0008210 | |
| GeneOntologyBiologicalProcess | amino-acid betaine metabolic process | 1.00e-04 | 18 | 290 | 4 | GO:0006577 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.19e-04 | 105 | 290 | 8 | GO:0006721 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | ILK CDKL3 NRP1 SEMA3A ZDHHC15 FBXW8 SYNE1 SHANK3 ACTR3 EPHA4 EPHA5 | 1.19e-04 | 198 | 290 | 11 | GO:0048813 |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | AP2B1 CLTC MMP14 SORBS2 DOK7 SORBS1 SHANK3 ACTR3 CEMIP LRP1 LRP5 EPHA3 | 1.42e-04 | 237 | 290 | 12 | GO:1905475 |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 1.46e-04 | 8 | 290 | 3 | GO:0150094 | |
| GeneOntologyBiologicalProcess | postsynapse organization | CARMIL3 LILRB2 LRRTM1 NRP1 ZDHHC15 NPTX1 SORBS2 DOK7 SORBS1 SHANK3 ACTR3 LRP5 EPHA4 EPHA5 | 1.50e-04 | 313 | 290 | 14 | GO:0099173 |
| GeneOntologyBiologicalProcess | neuron recognition | 1.77e-04 | 59 | 290 | 6 | GO:0008038 | |
| GeneOntologyBiologicalProcess | negative regulation of axon extension | 1.82e-04 | 38 | 290 | 5 | GO:0030517 | |
| GeneOntologyBiologicalProcess | skeletal muscle acetylcholine-gated channel clustering | 1.90e-04 | 21 | 290 | 4 | GO:0071340 | |
| GeneOntologyBiologicalProcess | bilirubin conjugation | 1.97e-04 | 2 | 290 | 2 | GO:0006789 | |
| GeneOntologyBiologicalProcess | fasciculation of motor neuron axon | 1.97e-04 | 2 | 290 | 2 | GO:0097156 | |
| GeneOntologyBiologicalProcess | brain renin-angiotensin system | 2.17e-04 | 9 | 290 | 3 | GO:0002035 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | CHST9 DUOX1 MME UGT1A10 UGT1A8 UGT1A7 UGT1A9 PAPSS2 SDR9C7 UGT1A1 UGT1A3 ACE2 CTSL | 2.20e-04 | 286 | 290 | 13 | GO:0042445 |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 2.33e-04 | 40 | 290 | 5 | GO:0097242 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.33e-04 | 40 | 290 | 5 | GO:0042573 | |
| GeneOntologyBiologicalProcess | synapse organization | CARMIL3 LILRB2 LRRTM1 NRP1 SEMA3A ZDHHC15 PTPRO FLRT2 SDK1 NPTX1 SDK2 SORBS2 DOK7 SORBS1 SHANK3 ACTR3 EFNB2 P2RX2 LRP5 EPHA3 EPHA4 EPHA5 | 2.95e-04 | 685 | 290 | 22 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 2.95e-04 | 42 | 290 | 5 | GO:0070316 | |
| GeneOntologyBiologicalProcess | nervous system process involved in regulation of systemic arterial blood pressure | 3.26e-04 | 24 | 290 | 4 | GO:0001976 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 3.68e-04 | 44 | 290 | 5 | GO:0045023 | |
| GeneOntologyBiologicalProcess | axonogenesis involved in innervation | 4.17e-04 | 11 | 290 | 3 | GO:0060385 | |
| GeneOntologyBiologicalProcess | cell junction assembly | CARMIL3 LRRTM1 NRP1 DLC1 PTPRO FLRT2 WDR1 MMP14 SDK1 NPTX1 SDK2 SORBS1 SHANK3 ACTR3 ACE2 EFNB2 LRP1 CDH18 EPHA3 | 4.75e-04 | 569 | 290 | 19 | GO:0034329 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 5.12e-04 | 130 | 290 | 8 | GO:1905477 | |
| GeneOntologyBiologicalProcess | basal dendrite arborization | 5.86e-04 | 3 | 290 | 2 | GO:0150020 | |
| GeneOntologyBiologicalProcess | fasciculation of sensory neuron axon | 5.86e-04 | 3 | 290 | 2 | GO:0097155 | |
| GeneOntologyBiologicalProcess | basal dendrite morphogenesis | 5.86e-04 | 3 | 290 | 2 | GO:0150019 | |
| GeneOntologyBiologicalProcess | basal dendrite development | 5.86e-04 | 3 | 290 | 2 | GO:0150018 | |
| GeneOntologyBiologicalProcess | facioacoustic ganglion development | 5.86e-04 | 3 | 290 | 2 | GO:1903375 | |
| GeneOntologyCellularComponent | focal adhesion | RPL31 STARD8 ILK RPS2 NRP1 FAT1 DLC1 CLTC MME FLRT2 MMP14 SORBS2 CAPN2 SORBS1 ACTR3 EFNB2 XIRP2 LRP1 | 3.95e-05 | 431 | 292 | 18 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | RPL31 STARD8 ILK RPS2 NRP1 FAT1 DLC1 CLTC MME FLRT2 MMP14 SORBS2 CAPN2 SORBS1 ACTR3 EFNB2 XIRP2 LRP1 | 5.64e-05 | 443 | 292 | 18 | GO:0030055 |
| GeneOntologyCellularComponent | somatodendritic compartment | ILK ELOVL5 DDN NCAM1 NRP1 ITPR3 JAM2 SEMA3A BPTF PTPRO ACAN CPT1C KCNAB1 IQCJ-SCHIP1 MME CACNA1D SORBS2 HTR3A SYNE1 CAPN2 SHANK3 EFNB2 CD22 P2RX2 CST1 LRP1 LRP2 KIRREL1 WDFY3 CTSL EPHA3 EPHA4 EPHA5 | 2.46e-04 | 1228 | 292 | 33 | GO:0036477 |
| GeneOntologyCellularComponent | anchoring junction | RPL31 STARD8 ILK RPS2 NCAM1 CEACAM1 NRP1 JAM2 FAT1 DLC1 PTPRM CLTC MME FLRT2 WDR1 MMP14 SORBS2 DSC2 CAPN2 SORBS1 ACTR3 EFNB2 XIRP2 LRP1 KIRREL1 CDH18 EPHA4 EPHA5 | 2.64e-04 | 976 | 292 | 28 | GO:0070161 |
| MousePheno | abnormal heart left ventricle wall morphology | 3.49e-06 | 99 | 220 | 10 | MP:0031533 | |
| MousePheno | cardiac hypertrophy | RNLS SEMA3A AP2B1 ACAN DSC2 LAMA4 TBC1D25 SLC7A7 ACE2 XIRP2 LRP2 CTSL DNAH11 | 1.36e-05 | 196 | 220 | 13 | MP:0001625 |
| MousePheno | abnormal heart left ventricle size | RNLS GBE1 TYK2 AP2B1 AGTR2 KLK1 DSC2 LAMA4 ERGIC3 LRP2 CTSL DNAH11 | 1.48e-05 | 169 | 220 | 12 | MP:0010578 |
| MousePheno | abnormal heart ventricle size | RNLS GBE1 TYK2 SEMA3A AP2B1 AGTR2 KLK1 DSC2 LAMA4 CERT1 ERGIC3 LRP2 CTSL DNAH11 | 1.52e-05 | 228 | 220 | 14 | MP:0031543 |
| MousePheno | abnormal heart ventricle wall morphology | RNLS SEMA3A DLC1 AP2B1 AGTR2 AP3M2 KLK1 DSC2 CAPN2 LAMA4 CERT1 ACE2 LRP2 WDFY3 CTSL DNAH11 | 1.85e-05 | 296 | 220 | 16 | MP:0031532 |
| MousePheno | abnormal atrioventricular node conduction | 4.74e-05 | 83 | 220 | 8 | MP:0006141 | |
| MousePheno | abnormal PR interval | 6.97e-05 | 65 | 220 | 7 | MP:0003901 | |
| MousePheno | heart left ventricle hypertrophy | 6.97e-05 | 65 | 220 | 7 | MP:0002625 | |
| Domain | UDPGT | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.05e-11 | 21 | 287 | 9 | PF00201 |
| Domain | UDP_glucos_trans | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.05e-11 | 21 | 287 | 9 | IPR002213 |
| Domain | UDPGT | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.05e-11 | 21 | 287 | 9 | PS00375 |
| Domain | fn3 | NCAM1 FNDC7 PTPRB PTPRG PTPRM PTPRO FLRT2 SDK1 SDK2 COL12A1 COL20A1 PRLR EPHA3 EPHA4 EPHA5 MYBPC2 | 4.26e-09 | 162 | 287 | 16 | PF00041 |
| Domain | FN3 | NCAM1 FNDC7 PTPRB PTPRG PTPRM PTPRO FNDC11 FLRT2 SDK1 SDK2 COL12A1 COL20A1 PRLR EPHA3 EPHA4 EPHA5 MYBPC2 | 1.26e-08 | 199 | 287 | 17 | PS50853 |
| Domain | FN3_dom | NCAM1 FNDC7 PTPRB PTPRG PTPRM PTPRO FNDC11 FLRT2 SDK1 SDK2 COL12A1 COL20A1 PRLR EPHA3 EPHA4 EPHA5 MYBPC2 | 2.62e-08 | 209 | 287 | 17 | IPR003961 |
| Domain | FN3 | NCAM1 FNDC7 PTPRB PTPRG PTPRM PTPRO FLRT2 SDK1 SDK2 COL12A1 COL20A1 PRLR EPHA3 EPHA4 EPHA5 MYBPC2 | 2.87e-08 | 185 | 287 | 16 | SM00060 |
| Domain | Ig-like_fold | HLA-DMB LILRB2 HAPLN2 GBE1 NCAM1 CEACAM1 JAM2 SEMA3A FNDC7 PTPRB PTPRG PTPRM PTPRO FNDC11 FLRT2 CAMTA1 SDK1 IGKV4-1 SDK2 COL12A1 COL20A1 OPCML CD22 KIRREL1 PRLR EPHA3 EPHA4 EPHA5 MYBPC2 | 1.57e-06 | 706 | 287 | 29 | IPR013783 |
| Domain | VAST | 3.59e-06 | 3 | 287 | 3 | PS51778 | |
| Domain | DUF4782 | 3.59e-06 | 3 | 287 | 3 | IPR031968 | |
| Domain | DUF4782 | 3.59e-06 | 3 | 287 | 3 | PF16016 | |
| Domain | - | HLA-DMB HAPLN2 GBE1 NCAM1 CEACAM1 JAM2 SEMA3A FNDC7 PTPRB PTPRG PTPRM PTPRO FNDC11 FLRT2 CAMTA1 SDK1 SDK2 COL12A1 COL20A1 OPCML CD22 KIRREL1 PRLR EPHA3 EPHA4 EPHA5 MYBPC2 | 4.31e-06 | 663 | 287 | 27 | 2.60.40.10 |
| Domain | MAGE_N | 1.06e-05 | 20 | 287 | 5 | SM01392 | |
| Domain | MAGE_N | 1.76e-05 | 22 | 287 | 5 | IPR021072 | |
| Domain | MAGE_N | 1.76e-05 | 22 | 287 | 5 | PF12440 | |
| Domain | MAGE | 1.60e-04 | 34 | 287 | 5 | SM01373 | |
| Domain | MAGE | 2.11e-04 | 36 | 287 | 5 | PS50838 | |
| Domain | MHD_dom | 2.11e-04 | 36 | 287 | 5 | IPR002190 | |
| Domain | MAGE | 2.11e-04 | 36 | 287 | 5 | PF01454 | |
| Domain | AMMECR1_domain | 2.35e-04 | 2 | 287 | 2 | IPR002733 | |
| Domain | - | 2.35e-04 | 2 | 287 | 2 | 3.30.700.20 | |
| Domain | AMMECR1 | 2.35e-04 | 2 | 287 | 2 | IPR023473 | |
| Domain | Betaine-hCys_S-MeTrfase_BHMT | 2.35e-04 | 2 | 287 | 2 | IPR017226 | |
| Domain | AMMECR1_N | 2.35e-04 | 2 | 287 | 2 | IPR027485 | |
| Domain | MAGEA3/MAGEA6 | 2.35e-04 | 2 | 287 | 2 | IPR030097 | |
| Domain | AMMECR1 | 2.35e-04 | 2 | 287 | 2 | PF01871 | |
| Domain | AMMECR1 | 2.35e-04 | 2 | 287 | 2 | PS51112 | |
| Domain | SAM | 4.13e-04 | 88 | 287 | 7 | SM00454 | |
| Domain | SAM_DOMAIN | 6.56e-04 | 95 | 287 | 7 | PS50105 | |
| Domain | Arp3_met | 6.99e-04 | 3 | 287 | 2 | IPR015623 | |
| Domain | HCY | 6.99e-04 | 3 | 287 | 2 | PS50970 | |
| Domain | Sorb | 6.99e-04 | 3 | 287 | 2 | SM00459 | |
| Domain | - | 6.99e-04 | 3 | 287 | 2 | 3.20.20.330 | |
| Domain | SoHo_dom | 6.99e-04 | 3 | 287 | 2 | IPR003127 | |
| Domain | SOHO | 6.99e-04 | 3 | 287 | 2 | PS50831 | |
| Domain | S-methyl_trans | 6.99e-04 | 3 | 287 | 2 | PF02574 | |
| Domain | HCY_dom | 6.99e-04 | 3 | 287 | 2 | IPR003726 | |
| Domain | Sorb | 6.99e-04 | 3 | 287 | 2 | PF02208 | |
| Domain | SAM | 7.43e-04 | 97 | 287 | 7 | IPR001660 | |
| Domain | START | 9.16e-04 | 13 | 287 | 3 | SM00234 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.15e-03 | 14 | 287 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.15e-03 | 14 | 287 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.15e-03 | 14 | 287 | 3 | IPR001426 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.15e-03 | 14 | 287 | 3 | IPR001090 | |
| Domain | Eph_TM | 1.15e-03 | 14 | 287 | 3 | IPR027936 | |
| Domain | EphA2_TM | 1.15e-03 | 14 | 287 | 3 | PF14575 | |
| Domain | EPH_lbd | 1.15e-03 | 14 | 287 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 1.15e-03 | 14 | 287 | 3 | PF01404 | |
| Domain | Ldl_recept_b | 1.15e-03 | 14 | 287 | 3 | PF00058 | |
| Domain | LDLRB | 1.15e-03 | 14 | 287 | 3 | PS51120 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.15e-03 | 14 | 287 | 3 | IPR016257 | |
| Domain | EPH_LBD | 1.15e-03 | 14 | 287 | 3 | PS51550 | |
| Domain | Toprim_domain | 1.38e-03 | 4 | 287 | 2 | IPR006171 | |
| Domain | TOPRIM | 1.38e-03 | 4 | 287 | 2 | PS50880 | |
| Domain | FAM47 | 1.38e-03 | 4 | 287 | 2 | PF14642 | |
| Domain | Toprim | 1.38e-03 | 4 | 287 | 2 | PF01751 | |
| Domain | FAM47 | 1.38e-03 | 4 | 287 | 2 | IPR032743 | |
| Domain | LY | 1.42e-03 | 15 | 287 | 3 | SM00135 | |
| Domain | START | 1.42e-03 | 15 | 287 | 3 | PS50848 | |
| Domain | LDLR_classB_rpt | 1.42e-03 | 15 | 287 | 3 | IPR000033 | |
| Domain | START_lipid-bd_dom | 1.42e-03 | 15 | 287 | 3 | IPR002913 | |
| Domain | START | 1.42e-03 | 15 | 287 | 3 | PF01852 | |
| Domain | GRAM | 1.73e-03 | 16 | 287 | 3 | SM00568 | |
| Domain | MAM_1 | 1.73e-03 | 16 | 287 | 3 | PS00740 | |
| Pathway | REACTOME_GLUCURONIDATION | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.45e-11 | 25 | 207 | 9 | M17787 |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.45e-11 | 25 | 207 | 9 | M605 |
| Pathway | WP_GLUCURONIDATION | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.71e-11 | 26 | 207 | 9 | M39404 |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.45e-10 | 28 | 207 | 9 | M19580 |
| Pathway | REACTOME_GLUCURONIDATION | 1.13e-09 | 24 | 207 | 8 | MM14599 | |
| Pathway | WP_GLUCURONIDATION | 1.65e-09 | 25 | 207 | 8 | MM15820 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | CES5A UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.84e-09 | 51 | 207 | 10 | M17726 |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | GBE1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.47e-09 | 52 | 207 | 10 | M14171 |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.22e-09 | 41 | 207 | 9 | M7399 |
| Pathway | WP_ESTROGEN_METABOLISM | 1.88e-08 | 22 | 207 | 7 | MM15888 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.45e-08 | 55 | 207 | 9 | M14933 |
| Pathway | REACTOME_ASPIRIN_ADME | 2.13e-07 | 44 | 207 | 8 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.55e-07 | 45 | 207 | 8 | MM15694 | |
| Pathway | KEGG_RETINOL_METABOLISM | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.65e-07 | 64 | 207 | 9 | M9488 |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.99e-07 | 70 | 207 | 9 | M16794 |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.02e-06 | 72 | 207 | 9 | M9257 |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.17e-06 | 14 | 207 | 5 | M39328 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PAPSS2 UGT1A4 UGT1A1 UGT1A3 | 4.52e-06 | 109 | 207 | 10 | M18788 |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 8.90e-06 | 51 | 207 | 7 | M27311 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | BAAT CHST9 KCNAB1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.59e-05 | 153 | 207 | 11 | MM15844 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 PAPSS2 UGT1A4 UGT1A1 UGT1A3 | 2.76e-05 | 107 | 207 | 9 | MM14595 |
| Pathway | REACTOME_DRUG_ADME | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.20e-05 | 109 | 207 | 9 | M45012 |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | ILK ATG4B UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A9 UGT1A4 UGT1A1 ARL4C | 5.53e-05 | 145 | 207 | 10 | M45512 |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 6.11e-05 | 92 | 207 | 8 | M27201 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | BAAT CHST9 KCNAB1 UGT1A10 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.25e-05 | 183 | 207 | 11 | M39588 |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 8.73e-05 | 72 | 207 | 7 | M39403 | |
| Pathway | KEGG_RENIN_ANGIOTENSIN_SYSTEM | 9.25e-05 | 17 | 207 | 4 | M17636 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 9.54e-05 | 73 | 207 | 7 | MM15906 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 1.18e-04 | 18 | 207 | 4 | M39424 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.82e-04 | 20 | 207 | 4 | MM14721 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.49e-04 | 39 | 207 | 5 | MM15695 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 3.09e-04 | 116 | 207 | 8 | MM14855 | |
| Pathway | WP_SARSCOV2_AND_COVID19_PATHWAY | 3.47e-04 | 10 | 207 | 3 | M40050 | |
| Pathway | REACTOME_DRUG_ADME | 3.67e-04 | 119 | 207 | 8 | MM15692 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 4.93e-04 | 45 | 207 | 5 | M39615 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 5.39e-04 | 126 | 207 | 8 | M705 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 6.23e-04 | 12 | 207 | 3 | M39611 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 8.04e-04 | 29 | 207 | 4 | M45015 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 1.01e-03 | 14 | 207 | 3 | M10122 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 1.04e-03 | 31 | 207 | 4 | M39476 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.18e-03 | 32 | 207 | 4 | MM14719 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 1.18e-03 | 32 | 207 | 4 | M39567 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.25e-03 | 15 | 207 | 3 | MM15697 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.14e-19 | 9 | 297 | 9 | 22511988 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.12e-18 | 10 | 297 | 9 | 23642732 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.12e-18 | 10 | 297 | 9 | 11465080 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.12e-18 | 10 | 297 | 9 | 23371916 | |
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.12e-18 | 10 | 297 | 9 | 22558097 |
| Pubmed | 2.57e-17 | 8 | 297 | 8 | 20610558 | ||
| Pubmed | 2.57e-17 | 8 | 297 | 8 | 17179145 | ||
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.60e-17 | 12 | 297 | 9 | 19419973 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.60e-17 | 12 | 297 | 9 | 11434514 |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.48e-16 | 13 | 297 | 9 | 22085899 |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.48e-16 | 13 | 297 | 9 | 25246029 |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.13e-16 | 14 | 297 | 9 | 21646302 | |
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.13e-16 | 14 | 297 | 9 | 10836148 |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.13e-16 | 14 | 297 | 9 | 9295054 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.13e-16 | 14 | 297 | 9 | 14672974 |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.32e-15 | 16 | 297 | 9 | 19414484 |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.09e-15 | 7 | 297 | 7 | 8467709 | |
| Pubmed | 3.09e-15 | 7 | 297 | 7 | 8464825 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.90e-15 | 17 | 297 | 9 | 20639394 |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.24e-14 | 12 | 297 | 8 | 20308471 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.83e-14 | 19 | 297 | 9 | 23281178 |
| Pubmed | 1.09e-13 | 9 | 297 | 7 | 1339448 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.50e-13 | 24 | 297 | 9 | 24625756 |
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 3.69e-13 | 6 | 297 | 6 | 19204906 | |
| Pubmed | 1.02e-11 | 8 | 297 | 6 | 18052087 | ||
| Pubmed | 4.39e-11 | 5 | 297 | 5 | 15057901 | ||
| Pubmed | 2.62e-10 | 6 | 297 | 5 | 20297805 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | SPTLC3 MAMSTR UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 DOK7 UGT1A9 UGT1A4 UGT1A1 UGT1A3 ERGIC3 LRP1 DNAH11 | 4.94e-10 | 211 | 297 | 15 | 24097068 |
| Pubmed | 4.96e-10 | 35 | 297 | 8 | 23716698 | ||
| Pubmed | Expression of melanoma-associated antigens in oral squamous cell carcinoma. | 9.09e-10 | 7 | 297 | 5 | 18197853 | |
| Pubmed | The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. | 1.05e-09 | 14 | 297 | 6 | 8575766 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.34e-09 | 57 | 297 | 9 | 21886157 |
| Pubmed | Structure, chromosomal localization, and expression of 12 genes of the MAGE family. | 1.73e-09 | 15 | 297 | 6 | 7927540 | |
| Pubmed | 2.41e-09 | 8 | 297 | 5 | 22579593 | ||
| Pubmed | MAGE cancer-testis antigens protect the mammalian germline under environmental stress. | 2.41e-09 | 8 | 297 | 5 | 31149633 | |
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 2.41e-09 | 8 | 297 | 5 | 12695355 | |
| Pubmed | The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice. | 2.41e-09 | 8 | 297 | 5 | 27226137 | |
| Pubmed | DDN GRAMD1B XPO5 RAB3GAP2 RRP12 CLTC KATNIP CHD6 CAMTA1 MTMR12 SORBS2 DNAJC16 SYNE1 DOCK9 SORBS1 MLXIP ATP9A RUBCN XPO7 | 2.95e-09 | 407 | 297 | 19 | 12693553 | |
| Pubmed | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.17e-09 | 66 | 297 | 9 | 19898482 | |
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 15855726 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 5.21e-09 | 4 | 297 | 4 | 2108603 | |
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 8280139 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 1634050 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 8276413 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 5.21e-09 | 4 | 297 | 4 | 18223459 | |
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 1898728 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 9535849 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 9271343 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 17558305 | ||
| Pubmed | 6.28e-09 | 18 | 297 | 6 | 20056724 | ||
| Pubmed | 1.95e-08 | 11 | 297 | 5 | 18695635 | ||
| Pubmed | 2.59e-08 | 5 | 297 | 4 | 8037761 | ||
| Pubmed | 3.31e-08 | 12 | 297 | 5 | 18161889 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RPL31 RPS2 TTC21A ELOVL5 GBE1 FASTKD5 NRP1 SEMA3A ZBP1 FAT1 CPT1C RAB3GAP2 CLTC C1R SCFD1 MMP11 GPD2 USP30 PDPR DSC2 ATP13A1 DNAJC16 UGT1A10 UGT1A8 UGT1A7 UGT1A9 CTSA SFXN1 IARS2 ERGIC3 CST1 LRP1 HAL RPL18A XPO7 | 3.74e-08 | 1451 | 297 | 35 | 30550785 |
| Pubmed | HLA-DMB NCAM1 CEACAM1 NRP1 JAM2 PTPRG PTPRM ACAN C1R CNDP1 DSC2 ATP13A1 LRP1 CTSL | 5.55e-08 | 257 | 297 | 14 | 16335952 | |
| Pubmed | 7.71e-08 | 6 | 297 | 4 | 32527940 | ||
| Pubmed | 1.23e-07 | 15 | 297 | 5 | 36028553 | ||
| Pubmed | 1.79e-07 | 7 | 297 | 4 | 22134685 | ||
| Pubmed | 1.79e-07 | 7 | 297 | 4 | 27514509 | ||
| Pubmed | 1.79e-07 | 7 | 297 | 4 | 17634428 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAGEA1 RPL31 LRWD1 ILK RPS2 ALKBH1 URB1 ATG4B RPL7L1 AP2B1 RRP12 CLTC SNRNP40 SCFD1 WDR1 MMP14 CAPN2 ADNP2 PAPSS2 ACTR3 SFXN1 RLF ORC1 METTL13 CSTF1 RACGAP1 WDFY3 RIOK2 YME1L1 TOP2A RPL18A FTSJ3 | 2.33e-07 | 1353 | 297 | 32 | 29467282 |
| Pubmed | 3.55e-07 | 8 | 297 | 4 | 15319294 | ||
| Pubmed | ITPR3 SPTBN5 SNRNP40 TACR2 SDK1 ANKRD13D DOCK2 SYNE1 CAPN2 CD22 LRP1 LRP5 | 3.66e-07 | 214 | 297 | 12 | 22199357 | |
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 6.17e-07 | 3 | 297 | 3 | 20007669 | |
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 12051676 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 19364970 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 29519853 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 11179460 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 12732365 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 20860988 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 19712005 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 19303655 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 16636344 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 17406868 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 19996319 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 12847094 | ||
| Pubmed | Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. | 6.17e-07 | 3 | 297 | 3 | 16969497 | |
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 15247627 | ||
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 26247833 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 6.17e-07 | 3 | 297 | 3 | 24453052 | |
| Pubmed | 6.17e-07 | 3 | 297 | 3 | 23789755 | ||
| Pubmed | URB1 XPO5 RAB3GAP2 MINAR1 CHD6 CAMTA1 ARAP1 DNAJC16 SYNE1 DOCK9 METTL13 WDFY3 | 6.25e-07 | 225 | 297 | 12 | 12168954 | |
| Pubmed | SPTLC3 BHMT UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.23e-07 | 190 | 297 | 11 | 24816252 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRWD1 BCL7A TTC3 ABCA7 CASZ1 ITPR3 TYK2 URB1 FAT1 RRP12 MMP14 TOP3B ARAP1 ANKRD13D ATP13A1 DOCK9 TSNARE1 AGPAT2 CHSY1 TBC1D25 MLXIP FBXO46 ORC1 C2CD3 LRP5 WDFY3 SOWAHB | 1.17e-06 | 1105 | 297 | 27 | 35748872 |
| Pubmed | RPL31 ILK RPS2 NRP1 FAT1 CLTC MME FLRT2 MMP14 CAPN2 ACTR3 EFNB2 LRP1 | 1.24e-06 | 285 | 297 | 13 | 21423176 | |
| Pubmed | 1.64e-06 | 11 | 297 | 4 | 22171039 | ||
| Pubmed | RALGAPA1 FASTKD5 TTC3 TRIP4 ITPR3 GRAMD1B URB1 RPL7L1 RAB3GAP2 RRP12 CLTC PARL SNRNP40 OS9 DNAJC1 SCFD1 TOP3B PDPR DSC2 ATP13A1 DNAJC16 SYNE1 GRAMD1A IARS2 EFNB2 FAM171A2 KIRREL1 LRRC61 ELP2 YME1L1 RPL18A FTSJ3 | 1.78e-06 | 1487 | 297 | 32 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 SPTLC3 TTC21A PFKFB1 TTC3 CASZ1 PPM1H NRP1 TYK2 BPTF PTPRB PTPRG VPS35L ACSF3 OS9 KATNIP PISD CHD6 MME CAMTA1 ARAP1 MOCOS TSNARE1 CERT1 SFXN1 RLF EFNB2 LRP1 LRP5 SNTG2 CNOT1 XPO7 | 1.83e-06 | 1489 | 297 | 32 | 28611215 |
| Pubmed | 2.45e-06 | 4 | 297 | 3 | 8113684 | ||
| Pubmed | 2.45e-06 | 4 | 297 | 3 | 24255116 | ||
| Pubmed | A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. | 2.45e-06 | 4 | 297 | 3 | 1840703 | |
| Pubmed | 2.45e-06 | 4 | 297 | 3 | 7775583 | ||
| Pubmed | 2.45e-06 | 4 | 297 | 3 | 15788771 | ||
| Pubmed | 2.45e-06 | 4 | 297 | 3 | 20628391 | ||
| Pubmed | ILK ITPR3 FANCC FBXW8 AP2B1 XPO5 CLTC OS9 WDR1 CTSA PPP1R10 IARS2 LRP1 CSTF1 YME1L1 TOP2A RPL18A XPO7 FTSJ3 | 2.76e-06 | 634 | 297 | 19 | 34591612 | |
| Pubmed | RPL31 RPS2 NCAM1 FAT1 CLTC SCFD1 FLRT2 SDK1 DSC2 DNAJC16 SFXN1 ARL4C IARS2 EFNB2 KIN FAM171A2 IFFO2 KIRREL1 MPHOSPH9 RPL18A XPO7 | 4.12e-06 | 777 | 297 | 21 | 35844135 | |
| Pubmed | RALGAPA1 PPM1H ITPR3 FBXO38 PTPRB PTPRG PTPRM RRP12 CLTC TOP3B GPD2 MTMR12 PDPR GRAMD1A ACTR3 PPP1R10 C2CD3 PPP2R5B FAM171A2 KIRREL1 ELP2 MPHOSPH9 YME1L1 CNOT1 FTSJ3 | 4.56e-06 | 1049 | 297 | 25 | 27880917 | |
| Pubmed | 4.88e-06 | 14 | 297 | 4 | 26941654 | ||
| Pubmed | 5.40e-06 | 52 | 297 | 6 | 26633812 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RPS2 PDK2 TMEM135 FASTKD5 CHEK1 TTC3 ITPR3 SPTBN5 RPL7L1 RAB3GAP2 RRP12 CLTC PARL ACSF3 EXOG DNAJC1 SCFD1 TOP3B GPD2 USP30 PDPR SYNE1 GRAMD1A ATG2B HARS2 IARS2 LRP2 YME1L1 TOP2A RPL18A FTSJ3 | 5.59e-06 | 1496 | 297 | 31 | 32877691 |
| Cytoband | 2q37 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.13e-13 | 31 | 297 | 9 | 2q37 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | ATG4B UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 ARL4C | 3.10e-07 | 226 | 297 | 11 | chr2q37 |
| GeneFamily | UDP glucuronosyltransferases | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.07e-11 | 32 | 206 | 9 | 363 |
| GeneFamily | Fibronectin type III domain containing | NCAM1 FNDC7 PTPRB PTPRG PTPRM PTPRO FLRT2 SDK1 SDK2 COL12A1 COL20A1 EPHA3 EPHA4 EPHA5 MYBPC2 | 4.46e-10 | 160 | 206 | 15 | 555 |
| GeneFamily | MAGE family | 5.65e-06 | 40 | 206 | 6 | 1136 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 8.41e-05 | 21 | 206 | 4 | 813 | |
| GeneFamily | Low density lipoprotein receptors | 3.83e-04 | 13 | 206 | 3 | 634 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 3.83e-04 | 13 | 206 | 3 | 1146 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 4.84e-04 | 14 | 206 | 3 | 1095 | |
| GeneFamily | Sterile alpha motif domain containing | 5.07e-04 | 88 | 206 | 6 | 760 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.25e-04 | 161 | 206 | 8 | 593 | |
| GeneFamily | StAR related lipid transfer domain containing | 5.99e-04 | 15 | 206 | 3 | 759 | |
| GeneFamily | Topoisomerases | 1.88e-03 | 6 | 206 | 2 | 1050 | |
| GeneFamily | Exportins | 2.61e-03 | 7 | 206 | 2 | 547 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | NCAM1 NR4A1 FREM1 SEMA3A AGTR2 MME FLRT2 DNM1 CACNA1D SORBS2 COL12A1 DSC2 ACE2 ATRNL1 LRP1 PLD5 TOP2A EPHA3 | 2.28e-06 | 357 | 290 | 18 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 6.93e-06 | 122 | 290 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500 | B3GALT1 CHEK1 SEMA3A TMEM132C ADAMTS15 ST8SIA4 CEMIP TMEM26 GRAMD1C EPHA4 | 1.39e-05 | 132 | 290 | 10 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | B3GALT1 SPTLC3 SAMD8 FREM1 SEMA3A TMEM132C DLC1 PTPRG PTPRO BHMT2 KCNAB1 MME FLRT2 ST8SIA4 DNM1 CACNA1D SORBS2 HTR3A DSC2 LAMA4 NFE2L3 C2CD3 GALNT5 TMEM26 EPHA4 EPHA5 | 2.19e-05 | 769 | 290 | 26 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | SEMA3A TMEM132C PTPRG ADAMTS15 FLRT2 CAMTA1 ST8SIA4 DNM1 CACNA1D CEMIP EPHA3 EPHA4 EPHA5 | 3.20e-05 | 243 | 290 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | B3GALT1 NCAM1 FREM1 SEMA3A ANAPC1 AGTR2 ADAMTS15 FLRT2 DNM1 SDK2 KIRREL1 TMEM26 EPHA3 | 4.29e-05 | 250 | 290 | 13 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | NR4A1 NRP1 FAT1 DLC1 PTPRG C1R MME FLRT2 DNM1 MMP14 LAMA4 PAPSS2 ATRNL1 LRP1 KIRREL1 CTSL EPHA3 ADAP2 | 4.48e-05 | 445 | 290 | 18 | GSM777043_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_500 | HLA-DMB DDN CHST9 NRP1 MEP1B GRAMD1B PTPRO UGT1A10 PAPSS2 SFXN1 NFE2L3 ACE2 ARL4C C2CD3 LRP2 MAPK4 EPHA4 | 4.76e-05 | 406 | 290 | 17 | gudmap_developingKidney_e15.5_S-shaped body_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | B3GALT1 SPTLC3 TMEM132C PTPRG PTPRO KCNAB1 MME FLRT2 DNM1 HTR3A DSC2 LAMA4 GALNT5 TMEM26 EPHA4 EPHA5 | 1.01e-04 | 390 | 290 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.85e-04 | 146 | 290 | 9 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | NR4A1 CEACAM1 NRP1 JAM2 DLC1 PTPRB PTPRG PTPRM C1R MMP14 SORBS2 DOCK9 LAMA4 PAPSS2 SHANK3 EFNB2 CTSL | 1.94e-04 | 456 | 290 | 17 | GSM777032_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_500 | 2.05e-04 | 22 | 290 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | B3GALT1 TMEM132C KCNAB1 MME FLRT2 HTR3A DSC2 GALNT5 TMEM26 EPHA4 EPHA5 | 2.07e-04 | 217 | 290 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | NR4A1 CEACAM1 NRP1 JAM2 DLC1 PTPRB PTPRG PTPRM C1R MMP14 SORBS2 DOCK9 LAMA4 PAPSS2 SHANK3 EFNB2 CTSL | 2.09e-04 | 459 | 290 | 17 | GSM777037_500 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FREM1 NRP1 TMEM132C DLC1 C1R FLRT2 DNM1 CACNA1D SYNE1 LAMA4 ATRNL1 LRP1 EPHA3 | 1.02e-09 | 200 | 297 | 13 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | ELOVL5 PFKFB1 ALDH1L1 CEACAM1 SEMA3A TMEM132C OSBPL1A MME AGPAT2 LAMA4 ATP9A SNTG2 | 2.81e-09 | 177 | 297 | 12 | f0edf04930692418953e4f00a917257804ec0ffd |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STARD8 ELOVL5 NRP1 DLC1 PTPRB PTPRG PTPRM DOCK9 SHANK3 EFNB2 LRP5 SMAD6 | 7.91e-09 | 194 | 297 | 12 | f159ef8541d75a4e98468947f231bb463bec922c |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FREM1 NRP1 TMEM132C DLC1 PTPRG C1R FLRT2 DNM1 COL12A1 SYNE1 LAMA4 LRP1 | 1.11e-08 | 200 | 297 | 12 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FREM1 NRP1 DLC1 PTPRG ACAN C1R FLRT2 DNM1 SYNE1 LAMA4 PAPSS2 LRP1 | 1.11e-08 | 200 | 297 | 12 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | ELOVL5 PFKFB1 ALDH1L1 CEACAM1 SEMA3A TMEM132C OSBPL1A MME AGPAT2 LAMA4 ATP9A | 3.38e-08 | 178 | 297 | 11 | 278bbea5cf8f0589f71675c7a3d00679391b5253 |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | TMEM135 ELOVL5 PFKFB1 ALDH1L1 CEACAM1 SEMA3A TMEM132C OSBPL1A MME AGPAT2 LAMA4 | 4.49e-08 | 183 | 297 | 11 | b177be283e1553fb1f69a346f1ba79ad00297fa2 |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | TMEM135 ELOVL5 PFKFB1 ALDH1L1 CEACAM1 SEMA3A TMEM132C OSBPL1A MME AGPAT2 LAMA4 | 4.49e-08 | 183 | 297 | 11 | 3f9011976782fa8aa95cdd6f00f07a91094d411b |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | JAM2 PTPRB PTPRG PTPRM SORBS2 DOCK9 BMERB1 SORBS1 SHANK3 SNTG2 SMAD6 | 5.60e-08 | 187 | 297 | 11 | 2d20193a6cacdfa4877457c97b0077408942186c |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | JAM2 PTPRB PTPRG PTPRM DOCK9 CHSY1 PAPSS2 SHANK3 EFNB2 SNTG2 SMAD6 | 5.60e-08 | 187 | 297 | 11 | 81affaab3fe3e1daea45ada6445e906ddd33950e |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | JAM2 DLC1 PTPRB PTPRG PTPRM SORBS2 SYNE1 DOCK9 SORBS1 SHANK3 EFNB2 | 5.91e-08 | 188 | 297 | 11 | e901a9bdf00b8e91806f445af66647373bf62661 |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | TMEM135 ELOVL5 GBE1 PFKFB1 ALDH1L1 CEACAM1 TMEM132C OSBPL1A MME AGPAT2 LAMA4 | 5.91e-08 | 188 | 297 | 11 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | PPM1H TMEM132C DLC1 PTPRB PTPRM DOCK9 CHSY1 SHANK3 OPCML EFNB2 SMAD6 | 6.24e-08 | 189 | 297 | 11 | c81787a8c662db5d7814c583dd64562857629e81 |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | JAM2 PTPRB PTPRG PTPRM SORBS2 DOCK9 SORBS1 SHANK3 EFNB2 SNTG2 SMAD6 | 6.59e-08 | 190 | 297 | 11 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | RPS2 FREM1 SEMA3A TMEM132C FAT1 PTPRG DNM1 OPCML ATRNL1 CTSL RPL18A | 7.33e-08 | 192 | 297 | 11 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | JAM2 PTPRB PTPRG PTPRM SYNE1 DOCK9 SORBS1 PAPSS2 SHANK3 SNTG2 SMAD6 | 8.14e-08 | 194 | 297 | 11 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | NRP1 DLC1 ANTXR2 C1R FLRT2 COL12A1 LAMA4 SORBS1 ATRNL1 LRP1 PLD5 | 8.14e-08 | 194 | 297 | 11 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | CARMIL3 NCAM1 TMEM132C SPTBN5 ACAN FLRT2 COL20A1 LAMA4 OPCML ATRNL1 | 9.54e-08 | 155 | 297 | 10 | 77fdae85d36efb776db977eb424b32487ef222e4 |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | HLA-DMB LILRB2 NRP1 MMP14 DSC2 SLC7A7 PAPSS2 WDFY3 TMEM26 CTSL ADAP2 | 1.05e-07 | 199 | 297 | 11 | 96070b5ffcbab4952970f43b536969ddd2ca5d14 |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | JAM2 PTPRB PTPRG PTPRM DOCK9 CHSY1 LCN6 EFNB2 EPHA3 SMAD6 EPHA4 | 1.05e-07 | 199 | 297 | 11 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FREM1 NRP1 DLC1 PTPRG C1R FLRT2 DNM1 COL12A1 SYNE1 LAMA4 LRP1 | 1.11e-07 | 200 | 297 | 11 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | ELOVL5 PFKFB1 ALDH1L1 CEACAM1 SEMA3A TMEM132C MME AGPAT2 LAMA4 ATP9A | 1.81e-07 | 166 | 297 | 10 | 7e5852891714465c6228c9f955fd511ec79d0e02 |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.31e-07 | 130 | 297 | 9 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | C_00|World / shred on cell type and cluster | RPL31 RPS2 NR4A1 CHD6 SORBS2 PGGHG MLXIP PPP1R10 YME1L1 RPL18A | 3.65e-07 | 179 | 297 | 10 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.65e-07 | 179 | 297 | 10 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CHST9 JAM2 SEMA3A FBXW8 ANTXR2 IQCJ IQCJ-SCHIP1 LAMA4 MAPK4 CDH18 | 3.84e-07 | 180 | 297 | 10 | fd8c2059fcb382ffbfe19e598e37a49e1d5637b5 |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | TMEM135 ELOVL5 PFKFB1 ALDH1L1 CEACAM1 TMEM132C OSBPL1A MME AGPAT2 LAMA4 | 3.84e-07 | 180 | 297 | 10 | d48a3d27357f7d184132a6805950f93080146b59 |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | NR4A1 JAM2 PTPRB PTPRG DOCK9 SORBS1 SHANK3 EFNB2 SNTG2 SMAD6 | 4.04e-07 | 181 | 297 | 10 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.04e-07 | 181 | 297 | 10 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | NRP1 ANTXR2 AGTR2 FLRT2 COL12A1 LAMA4 SORBS1 ATRNL1 LRP1 PLD5 | 4.70e-07 | 184 | 297 | 10 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.70e-07 | 184 | 297 | 10 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 4.70e-07 | 184 | 297 | 10 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 4.94e-07 | 185 | 297 | 10 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | PPM1H TMEM132C PTPRB DOCK9 CHSY1 SHANK3 OPCML EFNB2 SNTG2 SMAD6 | 5.45e-07 | 187 | 297 | 10 | 7876dcb4800c2e54874df3d933efb79307a64a97 |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.45e-07 | 187 | 297 | 10 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | JAM2 PTPRB PTPRG PTPRM SORBS2 DOCK9 SORBS1 SHANK3 EFNB2 SMAD6 | 5.73e-07 | 188 | 297 | 10 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-07 | 188 | 297 | 10 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.73e-07 | 188 | 297 | 10 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | JAM2 PTPRB PTPRG PTPRM DOCK9 SORBS1 SHANK3 EFNB2 SNTG2 SMAD6 | 5.73e-07 | 188 | 297 | 10 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-07 | 188 | 297 | 10 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.01e-07 | 189 | 297 | 10 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | PPM1H TMEM132C PTPRB DOCK9 CHSY1 SHANK3 OPCML EFNB2 SNTG2 EPHA4 | 6.01e-07 | 189 | 297 | 10 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.28e-07 | 74 | 297 | 7 | 216721986c3055f2d9b4702be9693b3a0892283c | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.28e-07 | 74 | 297 | 7 | a7f7ed7316c226e18ee62d0149be7404326817c6 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | CASZ1 NRP1 FAT1 PTPRB PTPRG SORBS2 SYNE1 SORBS1 PAPSS2 SMAD6 | 6.31e-07 | 190 | 297 | 10 | 7f3f419fffe02934b6f27b697f7a6401072491ed |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | NR4A1 JAM2 PTPRB PTPRM DOCK9 PAPSS2 SHANK3 EFNB2 SNTG2 SMAD6 | 6.31e-07 | 190 | 297 | 10 | 07b675befcd1d0a9c90cb17b5d22323468325d51 |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | JAM2 PTPRB PTPRG PTPRM DOCK9 SORBS1 SHANK3 EFNB2 SNTG2 SMAD6 | 6.31e-07 | 190 | 297 | 10 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | PPM1H TMEM132C PTPRB FLRT2 DOCK9 CHSY1 OPCML EFNB2 SNTG2 SMAD6 | 6.94e-07 | 192 | 297 | 10 | c0c34785a7bdf461722029b322e9184e3d9b3c26 |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-07 | 192 | 297 | 10 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | JAM2 PTPRB PTPRG PTPRM SORBS2 DOCK9 SHANK3 EFNB2 SNTG2 SMAD6 | 7.28e-07 | 193 | 297 | 10 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 7.28e-07 | 193 | 297 | 10 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | PPM1H TMEM132C PTPRB DOCK9 CHSY1 SHANK3 OPCML EFNB2 SMAD6 EPHA4 | 7.28e-07 | 193 | 297 | 10 | 2531266bc57339d4e2b22a88817008e32b8c1598 |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 7.28e-07 | 193 | 297 | 10 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | TMEM132C PTPRB DOCK9 CHSY1 PAPSS2 SHANK3 OPCML EFNB2 SMAD6 EPHA4 | 7.28e-07 | 193 | 297 | 10 | 01c2df9206f1527c578e808978e58196c35e72f5 |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 7.63e-07 | 194 | 297 | 10 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | TMEM132C PTPRB DOCK9 CHSY1 PAPSS2 SHANK3 OPCML EFNB2 SMAD6 EPHA4 | 7.63e-07 | 194 | 297 | 10 | b6cc849fa08599bff9839ef382d190cc964e273e |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 7.63e-07 | 194 | 297 | 10 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | NCAM1 DLC1 ANTXR2 KCNAB1 COL12A1 LAMA4 SORBS1 ATRNL1 LRP1 EPHA3 | 8.00e-07 | 195 | 297 | 10 | dd281a249854800f737dc22e0f375f66dfb5cf5f |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DLC1 ANTXR2 KCNAB1 C1R FLRT2 COL12A1 LAMA4 SORBS1 ATRNL1 LRP1 | 8.00e-07 | 195 | 297 | 10 | edd4cd8402af81737b2074f9dce71cc6ab09be7e |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | JAM2 SEMA3A PTPRB PTPRM DOCK9 SORBS1 SHANK3 EFNB2 SNTG2 SMAD6 | 8.00e-07 | 195 | 297 | 10 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | NCAM1 DLC1 ANTXR2 KCNAB1 COL12A1 LAMA4 SORBS1 ATRNL1 LRP1 EPHA3 | 8.00e-07 | 195 | 297 | 10 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.00e-07 | 195 | 297 | 10 | ba494be431916d43c1d480f65bed674c0722c710 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-07 | 195 | 297 | 10 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CEACAM1 NRP1 DLC1 PTPRB ANTXR2 SYNE1 SHANK3 EFNB2 TMEM26 SMAD6 | 8.38e-07 | 196 | 297 | 10 | 65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | CEACAM1 DLC1 PTPRB PTPRG PTPRM DOCK9 SORBS1 SHANK3 EFNB2 SMAD6 | 8.38e-07 | 196 | 297 | 10 | d37f714d4fb57e958f3738fdda085560813e5bb5 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DLC1 ANTXR2 C1R FLRT2 COL12A1 LAMA4 SORBS1 CEMIP ATRNL1 LRP1 | 8.77e-07 | 197 | 297 | 10 | ae0435f4b4a9cdedb1c201fc56921048390097bf |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DLC1 ANTXR2 C1R FLRT2 COL12A1 LAMA4 SORBS1 CEMIP ATRNL1 LRP1 | 8.77e-07 | 197 | 297 | 10 | 37f6b6f2809b952382eaebb642b0aad6371f4251 |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | JAM2 SEMA3A PTPRB PTPRM DOCK9 SORBS1 SHANK3 EFNB2 SNTG2 SMAD6 | 8.77e-07 | 197 | 297 | 10 | ebf9be068eaa658493fa7884fd19f34642922acb |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CEACAM1 JAM2 PTPRB PTPRM SYNE1 DOCK9 SHANK3 EFNB2 SMAD6 EPHA4 | 9.19e-07 | 198 | 297 | 10 | 440af8f90c7afa1c07000806bcf9110b70f489fb |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CEACAM1 JAM2 DLC1 PTPRB PTPRG PTPRM DOCK9 SHANK3 EFNB2 SMAD6 | 9.19e-07 | 198 | 297 | 10 | fa84bf8533d1b91d2c2bcf06b710670605072b89 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CEACAM1 JAM2 PTPRB PTPRM SYNE1 DOCK9 SHANK3 EFNB2 SMAD6 EPHA4 | 9.19e-07 | 198 | 297 | 10 | 451003a21162eeae90739fdb502bb50b362d80c8 |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-07 | 198 | 297 | 10 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | FREM1 TMEM132C ADAMTS15 MMP14 CACNA1D SDK2 SYNE1 LAMA4 PAPSS2 LRP1 | 9.62e-07 | 199 | 297 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NR4A1 JAM2 TMEM132C DLC1 PTPRG C1R FLRT2 COL12A1 LAMA4 SORBS1 | 9.62e-07 | 199 | 297 | 10 | 3835452e4848d7f7dd8651c17b746b271ef39688 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | FREM1 TMEM132C ADAMTS15 MMP14 SDK1 CACNA1D SYNE1 LAMA4 PAPSS2 LRP1 | 1.01e-06 | 200 | 297 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | TMEM132C DLC1 PTPRG SYNE1 CAPN2 LAMA4 SORBS1 ATP9A SHANK3 EPHA3 | 1.01e-06 | 200 | 297 | 10 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-06 | 200 | 297 | 10 | 5b4a54cd81bc4d9f5e92798362239e1aa1b70bee | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | FREM1 TMEM132C ADAMTS15 MMP14 CACNA1D SDK2 SYNE1 LAMA4 PAPSS2 LRP1 | 1.01e-06 | 200 | 297 | 10 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | FREM1 TMEM132C ADAMTS15 MMP14 CACNA1D SDK2 SYNE1 LAMA4 PAPSS2 LRP1 | 1.01e-06 | 200 | 297 | 10 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | TMEM132C DLC1 PTPRG SYNE1 CAPN2 LAMA4 SORBS1 ATP9A SHANK3 EPHA3 | 1.01e-06 | 200 | 297 | 10 | 68fce28690246895fd33354b30960ebcc31aa4cc |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Artery|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.01e-06 | 200 | 297 | 10 | 590d1c0f86f136c7e76ea107fbb8ac5ff1164386 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | FREM1 NRP1 TMEM132C ADAMTS15 MMP14 CACNA1D SDK2 LAMA4 PAPSS2 LRP1 | 1.01e-06 | 200 | 297 | 10 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | BL-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-06 | 200 | 297 | 10 | dc3d5af1d4b15cc258d456f9f450550874456299 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | TMEM132C DLC1 PTPRG SYNE1 CAPN2 LAMA4 SORBS1 ATP9A SHANK3 EPHA3 | 1.01e-06 | 200 | 297 | 10 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-06 | 200 | 297 | 10 | 622206c33640cb2694fe158e8dc55515bb7bd4f5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | HLA-DMB NRP1 JAM2 DLC1 PTPRB PTPRG PTPRM IQCJ-SCHIP1 DOCK9 LAMA4 | 1.01e-06 | 200 | 297 | 10 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-06 | 200 | 297 | 10 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | TMEM132C DLC1 PTPRG SYNE1 CAPN2 LAMA4 SORBS1 ATP9A SHANK3 EPHA3 | 1.01e-06 | 200 | 297 | 10 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 |
| ToppCell | Severe-Myeloid-Macrophages-FCN1-SPP1+|Severe / Condition, Lineage, Cell class and cell subclass | 1.01e-06 | 200 | 297 | 10 | b8cd209b810312793465b28bb2a6cbe5d94da91f | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | TMEM132C DLC1 PTPRG SYNE1 CAPN2 LAMA4 SORBS1 ATP9A SHANK3 EPHA3 | 1.01e-06 | 200 | 297 | 10 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | TMEM132C DLC1 PTPRG SYNE1 CAPN2 LAMA4 SORBS1 ATP9A SHANK3 EPHA3 | 1.01e-06 | 200 | 297 | 10 | 7136936d05ab344a560cf159684c881063b5430d |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.26e-06 | 159 | 297 | 9 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 160 | 297 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 160 | 297 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.55e-06 | 121 | 297 | 8 | 2ae870f822488799cd0ad85e7f72af64e33a867f | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-06 | 168 | 297 | 9 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 169 | 297 | 9 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 171 | 297 | 9 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 171 | 297 | 9 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-06 | 171 | 297 | 9 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| Drug | AC1MRQNQ | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.05e-18 | 9 | 291 | 9 | CID003522271 |
| Drug | DHPASiU | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.05e-18 | 9 | 291 | 9 | CID000197602 |
| Drug | 3-iodophenol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.05e-18 | 9 | 291 | 9 | CID000012272 |
| Drug | AC1L4J7U | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.05e-18 | 9 | 291 | 9 | CID000186631 |
| Drug | Chebi:32663 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.05e-18 | 9 | 291 | 9 | CID005460873 |
| Drug | 4-nitrophenyl)imidazole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.33e-16 | 11 | 291 | 9 | CID000123155 |
| Drug | AC1O5XMV | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.33e-16 | 11 | 291 | 9 | CID006442661 |
| Drug | bilirubin-phosphate | NCAM1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.46e-16 | 16 | 291 | 10 | CID005497144 |
| Drug | N-OH-DABZ | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.71e-15 | 12 | 291 | 9 | CID000051366 |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.71e-15 | 12 | 291 | 9 | CID000088735 |
| Drug | 2,4,6-TCB | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.71e-15 | 12 | 291 | 9 | CID000037247 |
| Drug | nonanoyl-N-methylglucamide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.71e-15 | 12 | 291 | 9 | CID000160090 |
| Drug | 7,7,7-triphenylheptanoic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.71e-15 | 12 | 291 | 9 | CID000276709 |
| Drug | tritanol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.50e-15 | 13 | 291 | 9 | CID000006457 |
| Drug | 5-azido-UDP-glucuronic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.50e-15 | 13 | 291 | 9 | CID003081279 |
| Drug | cotinine-N-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.50e-15 | 13 | 291 | 9 | CID000000411 |
| Drug | propranolol glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.52e-14 | 14 | 291 | 9 | CID000119515 |
| Drug | PCB-61 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.52e-14 | 14 | 291 | 9 | CID000036401 |
| Drug | Benzamidoxime hydrochloride | MOCOS UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.11e-14 | 21 | 291 | 10 | CID000069186 |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.76e-14 | 15 | 291 | 9 | CID000040469 |
| Drug | afloqualone | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.76e-14 | 15 | 291 | 9 | CID000002040 |
| Drug | naphthyl sulphate | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.76e-14 | 15 | 291 | 9 | CID000114775 |
| Drug | coumarin-3-carboxylic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.76e-14 | 15 | 291 | 9 | CID000010752 |
| Drug | sulforaphane nitrile | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.76e-14 | 15 | 291 | 9 | CID000543743 |
| Drug | N-methylpiperazine | UGT1A10 UGT1A8 SYNE1 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.63e-14 | 22 | 291 | 10 | CID000053167 |
| Drug | quercetin-3,4'-diglucoside | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.51e-14 | 16 | 291 | 9 | CID005320835 |
| Drug | 1'-hydroxyestragole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.51e-14 | 16 | 291 | 9 | CID000040003 |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.79e-13 | 17 | 291 | 9 | CID000003573 |
| Drug | 6-hydroxychrysene | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.79e-13 | 17 | 291 | 9 | CID000037766 |
| Drug | N-phenylmaleimide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 PAPSS2 UGT1A4 UGT1A1 UGT1A3 | 2.75e-13 | 25 | 291 | 10 | CID000013662 |
| Drug | SureCN12722713 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.54e-13 | 18 | 291 | 9 | CID005488034 |
| Drug | ethyl-beta-D-6-glucosiduronic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.54e-13 | 18 | 291 | 9 | CID000152226 |
| Drug | Br 2 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.54e-13 | 18 | 291 | 9 | CID003060900 |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.54e-13 | 18 | 291 | 9 | CID000036614 |
| Drug | ApApG | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.54e-13 | 18 | 291 | 9 | CID003081975 |
| Drug | C1 11-32 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.54e-13 | 18 | 291 | 9 | CID000443077 |
| Drug | C11131 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.54e-13 | 18 | 291 | 9 | CID000443076 |
| Drug | anisole | HLA-DMB UGT1A10 UGT1A8 SYNE1 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.57e-13 | 36 | 291 | 11 | CID000007519 |
| Drug | 9-OH-risperidone | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.64e-13 | 19 | 291 | 9 | CID000475100 |
| Drug | 5alpha-spirostan-3beta-ol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.64e-13 | 19 | 291 | 9 | CID000091433 |
| Drug | almokalant | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.64e-13 | 19 | 291 | 9 | CID003033962 |
| Drug | CARMINE | AP3M2 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.07e-12 | 28 | 291 | 10 | CID000014749 |
| Drug | erucin | DNM1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.07e-12 | 28 | 291 | 10 | CID000078160 |
| Drug | tectochrysin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.19e-12 | 20 | 291 | 9 | CID005281954 |
| Drug | AC1L1OBF | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.19e-12 | 20 | 291 | 9 | CID000032736 |
| Drug | 4'-hydroxydiclofenac | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.19e-12 | 20 | 291 | 9 | CID000116545 |
| Drug | trans-3'-hydroxycotinine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 CROT | 1.61e-12 | 29 | 291 | 10 | CID000000414 |
| Drug | estriol-16-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.07e-12 | 21 | 291 | 9 | CID000122281 |
| Drug | dulcin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.07e-12 | 21 | 291 | 9 | CID000009013 |
| Drug | tolcapone | RNLS UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.39e-12 | 30 | 291 | 10 | CID004659569 |
| Drug | AC1L9E0Q | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 YME1L1 | 2.39e-12 | 30 | 291 | 10 | CID000443095 |
| Drug | amonafide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.46e-12 | 22 | 291 | 9 | CID000050515 |
| Drug | amidoxime | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.62e-12 | 23 | 291 | 9 | CID000465967 |
| Drug | estradiol-3-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.62e-12 | 23 | 291 | 9 | CID000066651 |
| Drug | phenanthridine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.62e-12 | 23 | 291 | 9 | CID000009189 |
| Drug | AS-3201 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 8.89e-12 | 24 | 291 | 9 | CID000153948 |
| Drug | 5-MOP | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.37e-11 | 25 | 291 | 9 | CID000002355 |
| Drug | AzMC | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.37e-11 | 25 | 291 | 9 | CID000064986 |
| Drug | N-acetylbenzidine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.37e-11 | 25 | 291 | 9 | CID000018787 |
| Drug | 5,6-benzoquinoline | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.37e-11 | 25 | 291 | 9 | CID000006796 |
| Drug | AC1L9DGV | BTK UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.89e-11 | 36 | 291 | 10 | CID000417381 |
| Drug | l-borneol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 YME1L1 | 2.56e-11 | 37 | 291 | 10 | CID000010049 |
| Drug | scopoletin | RNLS EXOG UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.96e-11 | 50 | 291 | 11 | CID005280460 |
| Drug | diflunisal | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.08e-11 | 27 | 291 | 9 | CID000003059 |
| Drug | DiMeIQx | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.08e-11 | 27 | 291 | 9 | CID000104739 |
| Drug | N-hydroxy-4-aminobiphenyl | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.49e-11 | 28 | 291 | 9 | CID000081261 |
| Drug | H-Ni | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.49e-11 | 28 | 291 | 9 | CID000445665 |
| Drug | thymoquinone | CHEK1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.02e-11 | 40 | 291 | 10 | CID000010281 |
| Drug | AC1L1JAL | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.44e-11 | 29 | 291 | 9 | CID000004954 |
| Drug | 7-hydroxycoumarin glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.44e-11 | 29 | 291 | 9 | CID000125641 |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.44e-11 | 29 | 291 | 9 | CID005375667 |
| Drug | iberin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.44e-11 | 29 | 291 | 9 | CID000010455 |
| Drug | paricalcitol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.10e-11 | 30 | 291 | 9 | CID005281104 |
| Drug | dihydroartemisinin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.10e-11 | 30 | 291 | 9 | CID000107770 |
| Drug | AC1NFJIQ | RNLS UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.02e-10 | 42 | 291 | 10 | CID004659568 |
| Drug | 5-hydroxytryptophol | RNLS UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.02e-10 | 42 | 291 | 10 | CID000009061 |
| Drug | Invader | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 CEMIP UGT1A4 UGT1A1 UGT1A3 HAL | 1.10e-10 | 56 | 291 | 11 | CID006442259 |
| Drug | PCB 156 | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.27e-10 | 31 | 291 | 9 | CID000038019 |
| Drug | 4'-HPPH | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.27e-10 | 31 | 291 | 9 | CID000017732 |
| Drug | 4-ethylphenol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.27e-10 | 31 | 291 | 9 | CID000031242 |
| Drug | N-hydroxy-PhIP | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 YME1L1 | 1.32e-10 | 43 | 291 | 10 | CID000104954 |
| Drug | Muracein C | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.74e-10 | 32 | 291 | 9 | CID003086323 |
| Drug | indole-2-carboxylic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.74e-10 | 32 | 291 | 9 | CID000072899 |
| Drug | NNAL | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.74e-10 | 32 | 291 | 9 | CID000104856 |
| Drug | R(-)-Denopamine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.37e-10 | 33 | 291 | 9 | CID000003818 |
| Drug | norbuprenorphine | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.37e-10 | 33 | 291 | 9 | CID000114976 |
| Drug | AC1Q6OQG | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.37e-10 | 33 | 291 | 9 | CID000009686 |
| Drug | 6-methylsalicylic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.37e-10 | 33 | 291 | 9 | CID000011279 |
| Drug | BP-3,6-quinol | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.37e-10 | 33 | 291 | 9 | CID000119292 |
| Drug | geniposide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.37e-10 | 33 | 291 | 9 | CID000107848 |
| Drug | estragole | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.19e-10 | 34 | 291 | 9 | CID000008815 |
| Drug | naringenin chalcone | 3.30e-10 | 5 | 291 | 5 | ctd:C027329 | |
| Drug | anthrarobin | 3.30e-10 | 5 | 291 | 5 | ctd:C032186 | |
| Drug | AC1NOWCJ | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.25e-10 | 35 | 291 | 9 | CID005120112 |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.25e-10 | 35 | 291 | 9 | CID010436171 |
| Drug | estrone-3-glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.25e-10 | 35 | 291 | 9 | CID000115255 |
| Drug | salicylamide | ALKBH1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.25e-10 | 48 | 291 | 10 | CID000005147 |
| Drug | campestrol | EXOG UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.28e-10 | 49 | 291 | 10 | CID000010134 |
| Drug | muraglitazar | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.60e-10 | 36 | 291 | 9 | CID000206044 |
| Drug | glucoraphanin | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.60e-10 | 36 | 291 | 9 | CID000656556 |
| Disease | X-11442 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.66e-19 | 9 | 286 | 9 | EFO_0021236 |
| Disease | X-11441 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.66e-19 | 9 | 286 | 9 | EFO_0021235 |
| Disease | circulating cell free DNA measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.66e-19 | 9 | 286 | 9 | EFO_0004739 |
| Disease | bilirubin measurement, response to xenobiotic stimulus | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.66e-19 | 9 | 286 | 9 | EFO_0004570, GO_0009410 |
| Disease | bilirubin measurement, response to tenofovir | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.60e-18 | 10 | 286 | 9 | EFO_0004570, EFO_0009279 |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.60e-18 | 10 | 286 | 9 | EFO_0802185 |
| Disease | histidine betaine (hercynine) measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.60e-17 | 11 | 286 | 9 | EFO_0800972 |
| Disease | X-21796 measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.60e-17 | 11 | 286 | 9 | EFO_0800825 |
| Disease | insomnia, bilirubin measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.60e-17 | 11 | 286 | 9 | EFO_0004570, EFO_0004698 |
| Disease | aldosterone measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.60e-17 | 11 | 286 | 9 | EFO_0010219 |
| Disease | X-11793--oxidized bilirubin measurement | 7.06e-17 | 8 | 286 | 8 | EFO_0021260 | |
| Disease | Succinimide measurement | 7.06e-17 | 8 | 286 | 8 | EFO_0022118 | |
| Disease | X-11530 measurement | 7.06e-17 | 8 | 286 | 8 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 7.06e-17 | 8 | 286 | 8 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 7.06e-17 | 8 | 286 | 8 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 7.06e-17 | 8 | 286 | 8 | EFO_0800696 | |
| Disease | X-10458 measurement | 7.06e-17 | 8 | 286 | 8 | EFO_0800692 | |
| Disease | X-24849 measurement | 7.06e-17 | 8 | 286 | 8 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 7.06e-17 | 8 | 286 | 8 | EFO_0802740 | |
| Disease | X-16946 measurement | 7.06e-17 | 8 | 286 | 8 | EFO_0800766 | |
| Disease | biliverdin measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.43e-16 | 12 | 286 | 9 | EFO_0021033 |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 6.30e-16 | 9 | 286 | 8 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 6.30e-16 | 9 | 286 | 8 | EFO_0801036 | |
| Disease | X-11880 measurement | 6.30e-16 | 9 | 286 | 8 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 6.30e-16 | 9 | 286 | 8 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 6.30e-16 | 9 | 286 | 8 | EFO_0802127 | |
| Disease | X-21448 measurement | 3.13e-15 | 10 | 286 | 8 | EFO_0800816 | |
| Disease | X-23974 measurement | 3.13e-15 | 10 | 286 | 8 | EFO_0800867 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.51e-14 | 17 | 286 | 9 | EFO_0004611, EFO_0007800 |
| Disease | p-cresol glucuronide measurement | 3.38e-14 | 12 | 286 | 8 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 8.72e-14 | 13 | 286 | 8 | EFO_0802007 | |
| Disease | tissue factor measurement | MAMSTR UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A3 | 1.77e-13 | 21 | 286 | 9 | EFO_0010623 |
| Disease | pregnenetriol sulfate measurement | 2.38e-12 | 11 | 286 | 7 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 2.38e-12 | 11 | 286 | 7 | EFO_0600039 | |
| Disease | angiopoietin-related protein 1 measurement | 2.84e-12 | 18 | 286 | 8 | EFO_0801382 | |
| Disease | xanthurenate measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.63e-12 | 29 | 286 | 9 | EFO_0010551 |
| Disease | response to dolutegravir | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.97e-12 | 30 | 286 | 9 | EFO_0600017 |
| Disease | pregnenetriol disulfate measurement | 1.22e-11 | 13 | 286 | 7 | EFO_0800587 | |
| Disease | serum N-desmethylclozapine measurement | 2.17e-11 | 8 | 286 | 6 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 2.17e-11 | 8 | 286 | 6 | EFO_0600038 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 8.26e-11 | 5 | 286 | 5 | EFO_0801060 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 8.26e-11 | 5 | 286 | 5 | EFO_0801853 | |
| Disease | X-21441 measurement | 1.34e-10 | 17 | 286 | 7 | EFO_0800814 | |
| Disease | X-21339 measurement | 1.71e-09 | 7 | 286 | 5 | EFO_0800808 | |
| Disease | urate measurement, spine bone mineral density | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.68e-09 | 58 | 286 | 9 | EFO_0004531, EFO_0007701 |
| Disease | 5-hydroxyindole sulfate measurement | 4.29e-08 | 5 | 286 | 4 | EFO_0800085 | |
| Disease | vitamin D deficiency | 6.00e-08 | 37 | 286 | 7 | EFO_0003762 | |
| Disease | gallstones | RRP12 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.05e-07 | 108 | 286 | 10 | EFO_0004210 |
| Disease | thyroxine measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 LAMA4 UGT1A9 UGT1A4 UGT1A3 | 1.17e-07 | 83 | 286 | 9 | EFO_0005130 |
| Disease | hormone measurement | B3GALT1 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A3 | 1.30e-07 | 84 | 286 | 9 | EFO_0004730 |
| Disease | cholelithiasis | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.95e-07 | 88 | 286 | 9 | EFO_0004799 |
| Disease | vitamin D measurement, COVID-19 | 4.53e-07 | 49 | 286 | 7 | EFO_0004631, MONDO_0100096 | |
| Disease | indole-3-carboxylate measurement | 9.01e-07 | 3 | 286 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 9.01e-07 | 3 | 286 | 3 | EFO_0022216 | |
| Disease | free androgen index | TYK2 GRAMD1B URB1 PTPRG MINAR1 CACNA1D UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 DOK7 UGT1A9 UGT1A4 LRP5 | 4.38e-06 | 374 | 286 | 15 | EFO_0007005 |
| Disease | neuroblastoma, cutaneous melanoma | 6.76e-06 | 28 | 286 | 5 | EFO_0000389, EFO_0000621 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.76e-05 | 6 | 286 | 3 | EFO_0800566 | |
| Disease | metabolite measurement | FAM47A BAAT ALDH1L1 SEMA3A BPTF CZIB DNAJC16 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 FAM200B UGT1A4 UGT1A1 UGT1A3 | 3.82e-05 | 560 | 286 | 17 | EFO_0004725 |
| Disease | serum metabolite measurement | RALGAPA1 ALDH1L1 ABCA7 BHMT ANTXR2 BHMT2 WDR1 GPD2 SORBS2 DNAJC16 UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 DOK7 UGT1A9 PAPSS2 UGT1A4 UGT1A1 UGT1A3 ELP2 HAL | 5.54e-05 | 945 | 286 | 23 | EFO_0005653 |
| Disease | non-high density lipoprotein cholesterol measurement | RPL31 TYK2 BPTF DLC1 MAMSTR UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 ADNP2 UGT1A9 CERT1 UGT1A4 UGT1A1 UGT1A3 NFE2L3 ERGIC3 DNAH11 | 7.75e-05 | 713 | 286 | 19 | EFO_0005689 |
| Disease | FANCONI ANEMIA, COMPLEMENTATION GROUP C | 9.36e-05 | 2 | 286 | 2 | C3468041 | |
| Disease | indoleacetate measurement | 1.03e-04 | 10 | 286 | 3 | EFO_0021015 | |
| Disease | bilirubin measurement | MAMSTR MME UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 UGT1A9 MLXIP UGT1A4 UGT1A1 UGT1A3 ARL4C DNAH11 | 1.19e-04 | 442 | 286 | 14 | EFO_0004570 |
| Disease | testosterone measurement | B3GALT1 RPL31 STARD8 DCDC1 TYK2 SEMA3A GRAMD1B FBXO38 URB1 PTPRG ANAPC1 FAM186A FGD1 MINAR1 MME ARAP1 CACNA1D UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 DOK7 UGT1A9 UGT1A4 LRP5 PRLR | 1.31e-04 | 1275 | 286 | 27 | EFO_0004908 |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.86e-04 | 12 | 286 | 3 | DOID:3827 (implicated_via_orthology) | |
| Disease | X-24588 measurement | 2.40e-04 | 13 | 286 | 3 | EFO_0800898 | |
| Disease | vitamin D measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 DOK7 UGT1A9 UGT1A4 HAL EPHA5 DNAH11 | 4.79e-04 | 336 | 286 | 11 | EFO_0004631 |
| Disease | gonadal dysgenesis (implicated_via_orthology) | 5.55e-04 | 4 | 286 | 2 | DOID:14447 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 6.00e-04 | 147 | 286 | 7 | DOID:9352 (biomarker_via_orthology) | |
| Disease | congestive heart failure (biomarker_via_orthology) | 6.27e-04 | 107 | 286 | 6 | DOID:6000 (biomarker_via_orthology) | |
| Disease | Early Pregnancy Loss | 6.92e-04 | 109 | 286 | 6 | C3830362 | |
| Disease | Spontaneous abortion | 6.92e-04 | 109 | 286 | 6 | C0000786 | |
| Disease | Miscarriage | 6.92e-04 | 109 | 286 | 6 | C4552766 | |
| Disease | Abortion, Tubal | 6.92e-04 | 109 | 286 | 6 | C0000822 | |
| Disease | pancreatic cancer (is_implicated_in) | 7.98e-04 | 112 | 286 | 6 | DOID:1793 (is_implicated_in) | |
| Disease | antihyperlipidemic drug use measurement | 9.16e-04 | 115 | 286 | 6 | EFO_0803367 | |
| Disease | diastolic blood pressure, systolic blood pressure | RPL31 DCDC1 CASZ1 DLC1 ACAN ADAMTS15 CHD6 CACNA1D DOK7 CHSY1 HDDC2 CBFA2T3 CEMIP C2CD3 LRP1 SMAD6 | 9.21e-04 | 670 | 286 | 16 | EFO_0006335, EFO_0006336 |
| Disease | disease progression measurement, Crohn's disease | 1.11e-03 | 47 | 286 | 4 | EFO_0000384, EFO_0008336 | |
| Disease | trypsin-1 measurement | 1.37e-03 | 6 | 286 | 2 | EFO_0020790 | |
| Disease | parenchymal hematoma, response to recombinant tissue-plasminogen activator | 1.37e-03 | 6 | 286 | 2 | EFO_0020101, EFO_0600080 | |
| Disease | thalamus volume | 1.44e-03 | 85 | 286 | 5 | EFO_0006935 | |
| Disease | corpus callosum posterior volume measurement | 1.62e-03 | 52 | 286 | 4 | EFO_0010298 | |
| Disease | Pancytopenia | 1.99e-03 | 26 | 286 | 3 | C0030312 | |
| Disease | apolipoprotein B measurement | CASZ1 BPTF PISD UGT1A10 UGT1A8 UGT1A7 UGT1A6 UGT1A5 DOK7 UGT1A9 CERT1 UGT1A4 UGT1A3 NFE2L3 DNAH11 | 2.22e-03 | 663 | 286 | 15 | EFO_0004615 |
| Disease | gestational age | 2.33e-03 | 138 | 286 | 6 | EFO_0005112 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 2.43e-03 | 58 | 286 | 4 | DOID:10652 (biomarker_via_orthology) | |
| Disease | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation | 2.52e-03 | 8 | 286 | 2 | EFO_0007681, EFO_0009308 | |
| Disease | 7-methylguanine measurement | 2.52e-03 | 8 | 286 | 2 | EFO_0021123 | |
| Disease | Pena-Shokeir syndrome type I | 2.52e-03 | 8 | 286 | 2 | C1276035 | |
| Disease | respiratory failure, COVID-19 | 2.73e-03 | 29 | 286 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | Post-Traumatic Osteoporosis | 2.92e-03 | 61 | 286 | 4 | C0751406 | |
| Disease | Osteoporosis, Senile | 2.92e-03 | 61 | 286 | 4 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 2.92e-03 | 61 | 286 | 4 | C0001787 | |
| Disease | corpus callosum volume measurement | 2.94e-03 | 100 | 286 | 5 | EFO_0010299 | |
| Disease | urate measurement, bone density | SPTLC3 GBE1 CASZ1 FREM1 GRAMD1B PTPRG SCFD1 UGT1A10 UGT1A8 SYNE1 UGT1A7 UGT1A6 UGT1A9 DNAH11 | 3.10e-03 | 619 | 286 | 14 | EFO_0003923, EFO_0004531 |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 3.22e-03 | 9 | 286 | 2 | EFO_0800517 | |
| Disease | premature birth | 3.22e-03 | 9 | 286 | 2 | EFO_0003917 | |
| Disease | Osteoporosis | 3.29e-03 | 63 | 286 | 4 | C0029456 | |
| Disease | PR interval | ALDH1L1 SEMA3A FAT1 DLC1 CHD6 FLRT2 CAMTA1 CACNA1D TMEM26 CNOT1 DNAH11 XPO7 | 3.47e-03 | 495 | 286 | 12 | EFO_0004462 |
| Disease | Large cell carcinoma of lung | 3.63e-03 | 32 | 286 | 3 | C0345958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YKGHVNWEILTPIRA | 421 | A0A0G2JMD5 | |
| AVQIRRRKASGDPYW | 46 | P23470 | |
| DGSWYRALVKEILPN | 776 | Q9BXT4 | |
| ALGKIPQTVLWRYTG | 326 | P35503 | |
| TLTEHVIRGLLKYWP | 311 | Q15173 | |
| LEPRVATRWDIQKYA | 271 | Q93088 | |
| IRWLSQGKILSRVYE | 386 | P0CF97 | |
| KLTRYLNWIGTPTKV | 61 | P16118 | |
| LTLERWYVAPGVTRI | 126 | Q14032 | |
| WYVAPGVTRIKVREG | 131 | Q14032 | |
| RVSTDLKYRKQPWGL | 451 | Q8IYS0 | |
| EILNIRTKGRTWYIL | 181 | Q5SQH8 | |
| AVVLYKWDRRAISIP | 1126 | Q9Y6Y1 | |
| YPLFVTWKTGRDKRL | 136 | Q6DCA0 | |
| RPLWKSYSRCTDGII | 76 | P56559 | |
| PSDVYRVWKRGESLR | 141 | Q6ZTN6 | |
| YWRLLSTDPVTAKEV | 526 | P63010 | |
| SARITIPDIKKDRWY | 251 | O14757 | |
| LYVFSPTEELRKRWI | 111 | Q06187 | |
| PRSLLEKLRWVTVGY | 161 | Q13686 | |
| KLAEPWKVYLRRFGT | 1001 | Q86V15 | |
| VATRWYRAPELVLKD | 161 | Q8IVW4 | |
| VATRWYRAPELLVGD | 161 | Q5MAI5 | |
| WPGKSDVDQLYLIIR | 201 | Q5MAI5 | |
| IQVYRSRKWRPIASD | 301 | Q9HD20 | |
| TYATKWPIRHGIIED | 71 | Q9P1U1 | |
| AAYTTRGGKIPIRWT | 831 | P54756 | |
| VIKYIWRIGTDGRTV | 246 | Q15760 | |
| AVAPYVSWIRKVTGR | 241 | P51124 | |
| YVINGGPIRDVRSKW | 206 | Q9Y5Z6 | |
| LLTNYRKGVRPVRDW | 41 | P46098 | |
| SVFRVPITWLQGKRE | 331 | P50052 | |
| QTKWYTPIKGRLDAL | 441 | P58335 | |
| RGPSYIWTFRLKSEE | 4486 | Q96DT5 | |
| YWIRGRTSVDIIKTG | 466 | Q4G176 | |
| TPSKYLRNIDGEAWV | 161 | P23109 | |
| KRLDPRIYRDVLGAW | 271 | O94850 | |
| RPTFGITWRYRLQTV | 1886 | Q12830 | |
| RVYDVVTPKIEAWRR | 661 | Q6ZW61 | |
| RGWKLRYTTEIIKCP | 296 | P00736 | |
| RYVSRGPWTRVLEKL | 1296 | Q8WUJ3 | |
| QYPRGSSDRWDKIAR | 511 | Q96KC8 | |
| VTEWLKYIPSSLNVR | 321 | O43155 | |
| GKEIPRWINRLAYFS | 121 | Q9BSY9 | |
| IRYKKLTDPTGWVTI | 506 | Q02487 | |
| TRGLTYTVLPSWVKN | 111 | P0CG01 | |
| DLVWLPIEQYRKDGR | 1906 | Q96BY7 | |
| LRVSSEIRYRKQPWS | 491 | Q96CP6 | |
| LRVSTELRYRKQPWG | 496 | Q3KR37 | |
| ELRYRKQPWGLVKTF | 501 | Q3KR37 | |
| ETSEPVWILGRKYSI | 21 | Q9Y4P1 | |
| RLTLAVAWVPKYSGV | 596 | Q8TE58 | |
| DPASRRGIWELLLKY | 971 | Q8IZY2 | |
| WKAGLTIVTPERRFV | 326 | Q9NPF8 | |
| VSLWEPSGKKVRYRT | 56 | Q6IQ32 | |
| WRGLPASINTAYERK | 361 | P50281 | |
| AWREYLQRQEPLGKR | 56 | Q1A5X6 | |
| KSTWLRPIVNGEEGY | 446 | A0A1B0GVH7 | |
| RLWTEIPTAITIKDY | 801 | Q14573 | |
| SWVELTLPFARKYGR | 886 | Q17RG1 | |
| KKRTARTDYWLQPEI | 271 | O60870 | |
| ASYDKRIILWDIGVP | 411 | Q9UFC0 | |
| TYEGLRAWTEQLPKA | 166 | P22736 | |
| IWDRKLTPGEVYNLA | 381 | Q15818 | |
| PRYWELLIDLSKGTQ | 1671 | Q9H1A4 | |
| KRVWPASQRDVLYLS | 496 | Q9Y5P4 | |
| QLSVVPWRRTGVKYT | 161 | P53677 | |
| IRAAGPWTTRLREIY | 1336 | Q9NRD9 | |
| VIYAPRRGILEVWST | 466 | Q9H2M9 | |
| FARRGWTYDSVKTPI | 1001 | Q5HY64 | |
| SDWGLPYRREVEVLA | 541 | Q14517 | |
| KIRWNDGLDQYRLTP | 376 | O95340 | |
| TKRVWIYLNGGRPED | 1666 | M0R2J8 | |
| GLVPGRKYVLWVVTH | 1231 | P23467 | |
| GQSPRRLIYKVSNWD | 66 | A0A075B6S6 | |
| RLIYKVSNWDSGVPD | 71 | A0A075B6S6 | |
| GGKDWSPTLYIRLVQ | 471 | P43304 | |
| YRSRDRKWIVLFPEG | 171 | Q92604 | |
| KAEPIDIQTWILGYR | 261 | Q92604 | |
| DIQTWILGYRKPTVT | 266 | Q92604 | |
| WGPRALAETSYVKVL | 266 | P43355 | |
| FLWGPRALIETSYVK | 271 | P43356 | |
| FLWGPRALVETSYVK | 271 | P43357 | |
| FLWGPRALIETSYVK | 271 | P43360 | |
| WGPRALAETSYVKVL | 276 | P43361 | |
| FLWGPRALVETSYVK | 271 | P43365 | |
| PSVAVRVLSYVKWIE | 241 | P06870 | |
| YKVRWSKVEPGELRE | 66 | Q9GZV7 | |
| IEGPEIKVWAQRYLR | 631 | Q9C0I1 | |
| YWAAVRELLPGLKVI | 146 | Q9BV99 | |
| RLTYIEPRILNSWKS | 291 | Q86UE6 | |
| TRVKGWFLLDNYIPT | 21 | Q9NYP7 | |
| VERPYLTDKIGWLDS | 576 | Q9NS40 | |
| SEGLVTKWYRSPRLL | 186 | P31152 | |
| WKASFLRAGVYPERV | 616 | Q05193 | |
| KLVEASYPGQDRWLR | 386 | Q5MY95 | |
| VWSPVRGAELYETKA | 391 | Q5VTL7 | |
| LPYGQRLVIDIKSTW | 971 | O60303 | |
| RRSSLVITTKLYWGG | 161 | Q14722 | |
| PNGLTVDYLEKRILW | 1436 | Q07954 | |
| PLRRYGAVEETAWKT | 16 | Q96MC5 | |
| RKIIVDSDIYWPNGL | 186 | O75197 | |
| YRSAPERTEDVWQKI | 641 | Q8ND23 | |
| EAAYTTRGGKIPIRW | 776 | P54764 | |
| SPVYLLDRERAWKLE | 311 | Q5T2Q4 | |
| RTAISKSIVLEPIYW | 21 | P52799 | |
| LNIWDLRTGKYPVHR | 281 | Q8N3Y1 | |
| EGRVLLDTWYVIKPG | 81 | Q6PJ61 | |
| DVTWKYTALNLIGPR | 616 | Q8NCN5 | |
| YRRRGWAFKNPDTIE | 166 | Q9Y282 | |
| SLGQRLKEPRVDFWT | 526 | Q6NT32 | |
| WPGKSQKIRSRYLED | 516 | Q9Y4A8 | |
| KSESAWLPVYIRAGI | 276 | Q5H8C1 | |
| WLKRNVIPETSSRYG | 91 | P08473 | |
| AGRVVYKTLEDPWIG | 456 | Q9Y2G8 | |
| RRKWLIPGAEYSIFT | 676 | Q99550 | |
| RILQPERYDLWKRGQ | 326 | Q6B0I6 | |
| LLGPWYVLAVASREK | 31 | P62502 | |
| YREKKSASWITRIRP | 61 | Q8N423 | |
| FSGVRYPLSWIEEVK | 206 | Q96EN8 | |
| YPLSWIEEVKSGRLH | 211 | Q96EN8 | |
| ALSYDQAKRVPRWVL | 81 | Q9Y2C4 | |
| ITVDPARGKLYWSDQ | 1876 | P98164 | |
| IVYSWVIRRDSKIPG | 356 | O75110 | |
| YTWFKDGIRLLENPR | 166 | P57087 | |
| VEWSPREEKYHLRGV | 411 | Q32M88 | |
| RTLTGYVPEDIWRKA | 476 | O75081 | |
| VVLEHGVLSWYRKQP | 256 | Q9BXW6 | |
| YRLKRSWGAVSREPL | 356 | Q3MIN7 | |
| SLTRVGLAKVLYAPW | 36 | Q96ES6 | |
| LPIELRDSYRKGFWT | 31 | Q8TCD6 | |
| GYNTRWAKIILPRLI | 56 | Q2TAA2 | |
| DSVERLPVYNKSAWR | 366 | Q15119 | |
| WLADRSVRYPISKAR | 301 | P16112 | |
| VVLSWTRPYLGVFRK | 546 | Q16827 | |
| LERDGKLPYNWRRSI | 866 | Q16827 | |
| SGVLEWQEKRRPYSD | 96 | Q86YD1 | |
| RKEGRQLYWTFVSPQ | 271 | A8MVW0 | |
| TWKQRTPFEGILIIY | 706 | Q8NB91 | |
| YAGNDKWSIDPRVII | 76 | Q14982 | |
| TRFVRIKPATWETGI | 401 | O14786 | |
| VQRRPWLVKYGDSGE | 421 | P10619 | |
| TRLKTRKTYSWVGRP | 6 | Q13415 | |
| RKTYSWVGRPLLDRK | 11 | Q13415 | |
| WDYETPKVIVVRNRR | 26 | Q9UBL9 | |
| EVWIPKNGTRRYSER | 611 | Q6PIJ6 | |
| PEAITTEGKYWKSRI | 201 | Q9HAP2 | |
| PVLQEIYLSGLRSWK | 26 | Q8TCG5 | |
| TYATKWPIRHGIVED | 71 | P61158 | |
| YPAEVTITWRKNGKL | 141 | P28068 | |
| RISPWAKYVVREGDN | 156 | Q04446 | |
| LVADLWRYLGRKVPR | 246 | Q7L8L6 | |
| LEKVYDLVRSVVRPW | 576 | P42357 | |
| RGYVKAGLWTPEAVI | 36 | Q9H2M3 | |
| KRAEVTRGPSLLWYF | 1471 | Q4AC94 | |
| TAYKLPGILRWFEVV | 1471 | Q92608 | |
| GYSWLPLLKDGRVVT | 756 | Q9BZ29 | |
| KLWERLPQETRDSYG | 221 | Q8NEX9 | |
| ALEKTGDLRYLWRPA | 46 | Q96LM5 | |
| ITWTQAPGRVLRYRI | 741 | Q99715 | |
| VKWDPASGRVQKYRI | 1771 | Q99715 | |
| YSFSEWPKDRVIINR | 2086 | Q8TD26 | |
| LSINPVKREDAGTYW | 381 | P13688 | |
| KYLIVWRASRGGTPR | 406 | Q9P218 | |
| HSENLPGTRRYWIKE | 51 | Q8NEG2 | |
| SALWKDRPIRGKEYV | 136 | A6NCJ1 | |
| GWLEPLLERVYLSRK | 596 | Q7Z7M9 | |
| QLLEPEAWKTYTERR | 31 | Q9BVV2 | |
| RPDQISRWYGKRKVE | 61 | Q8N1D5 | |
| YRWNRLGIESPRSEK | 531 | Q00597 | |
| RIPYKDTFWKGTTRT | 161 | Q13418 | |
| ESWRSEVGKQLRPLY | 166 | Q9BYF1 | |
| KVSPWVGLRKINISY | 806 | Q5VV63 | |
| EAAYTTRGGKIPIRW | 776 | P29320 | |
| RLPGTIWSYTQVRRT | 156 | Q5TF58 | |
| GVRPWKRAAILNYTK | 96 | O75426 | |
| SQRWRESKPRGNLTY | 86 | Q6ZN01 | |
| RTTKVLDREETPWYN | 441 | Q13634 | |
| RGWTYDSVKTPIQRA | 761 | Q5JRC9 | |
| KSWRLYKVFTQRVPD | 141 | Q8NFN8 | |
| LKAWPRYRVVGSADA | 66 | Q96J84 | |
| QLKRVPRTGWVYRNV | 26 | Q7Z4H3 | |
| KLLIYWASTRESGVP | 71 | P06312 | |
| WLYAKQRRSPKETVT | 261 | Q8WWI5 | |
| VGTDQTTRLFAPWKR | 406 | Q6IA86 | |
| SYKWKTDSIIGPIRL | 526 | Q86UP6 | |
| EIYEVPWENRRSLVK | 121 | P01037 | |
| PAVTGQWKLSDLRRY | 146 | Q18PE1 | |
| QWKLSDLRRYGAVPS | 151 | Q18PE1 | |
| PRWKSVLKDVQRSYE | 1011 | A6NE01 | |
| KLWEISTGRTLVRYT | 331 | Q05048 | |
| LRKPGRGWDDTYVLS | 676 | Q8N6R0 | |
| VTVGDTSLRIYKWVP | 36 | Q4VC05 | |
| YSSKTRGIEWKRPTE | 66 | P17655 | |
| IWYKRLTLFSGRDIP | 156 | Q8ND90 | |
| YKLRIRVRGNLEWAP | 681 | Q92622 | |
| KGWVLGRDYSRVEAP | 576 | O43304 | |
| PRVSLRYVWKKDNVA | 601 | Q7Z5N4 | |
| RPGYDGKTSISRWIV | 1091 | Q7Z5N4 | |
| HDPRVTIRYIWEKDG | 521 | Q58EX2 | |
| RNSIIGEKYRWPHTI | 61 | Q16820 | |
| KRIWSEYDPEAKGRI | 1486 | Q01668 | |
| TNLRPVGEDFRWYLK | 16 | Q9NWV4 | |
| AYSVIGLTLWRRAVP | 216 | P21452 | |
| ASKAWTLEVLYAPRR | 581 | P20273 | |
| TRWAKAREYLIGLDP | 246 | Q9UKG9 | |
| VRENLKVWIYPEGTR | 161 | O15120 | |
| VKSRQITIRWEPFGY | 391 | P28827 | |
| SWPAYFSIVKIERVG | 926 | Q16363 | |
| AEVKRGQPSWTIEEY | 821 | Q9UPX6 | |
| VTYGHELIWKNREPL | 346 | Q9H300 | |
| TEVSKYLGRVWFPDV | 416 | Q9UKT6 | |
| EKTDLTYRILRFPWQ | 106 | P24347 | |
| RPVLSKYRVEVLFWG | 986 | Q2WGJ9 | |
| RRPKGYELRVTIWNT | 1591 | Q2WGJ9 | |
| AKLWRLVNSPRYRSI | 16 | Q4G112 | |
| DTPEDKYGIKVTWRR | 201 | Q9BSD3 | |
| YHVGKVWRRESPTIV | 151 | P49590 | |
| RVTEVKKEPRYWLLA | 26 | Q6ZUK4 | |
| IKEPRWDQSTFIGRA | 11 | Q9H9B4 | |
| KSRVPQTWSKRLYGV | 276 | Q8N7P1 | |
| HGGVEPSLRKVVWRY | 226 | Q3MII6 | |
| ILLSKEPDGVWAYNR | 391 | O43541 | |
| WIIKYGRRESVEQLL | 526 | Q8NF91 | |
| ITWQVEYPRKGTTDI | 401 | Q8N3T6 | |
| SVRRLDPEYWKTILS | 141 | Q96LT4 | |
| YVTWGFPNLKSVREL | 146 | Q6DKI1 | |
| KRVESSVYWPAKRGI | 321 | Q587J7 | |
| EWDRYPRIGDILQKL | 446 | P98174 | |
| VWDTTSRRILYKLPG | 311 | Q96DI7 | |
| TKVFRSRDYQPLLWI | 156 | Q8IY81 | |
| IHAVRGYWLTNKVPI | 261 | Q92187 | |
| GIWSRDIRYKSNLPL | 106 | Q9H1D9 | |
| VYVWTLSDPETRVKI | 556 | O75083 | |
| YIKEPKSVFRTGWIS | 851 | Q9NSE4 | |
| RYEKRWLDTLSVPLS | 211 | Q9NY99 | |
| DAVIYGQPRTRRAWK | 286 | Q9NUV7 | |
| KDFQKIVWPVSYTRR | 86 | Q14563 | |
| AWREYLQRQEPLGKR | 56 | B3KU38 | |
| SPLRVKNFGIWLRYD | 71 | Q02543 | |
| IETVPYWTRSRRKTG | 236 | Q9H0H5 | |
| DYVVLRTWRTNLPKG | 1426 | Q96QB1 | |
| RVNVRDSSGKKPWQY | 696 | A6NEL2 | |
| KGLLRSILTYWRPVI | 2056 | O60287 | |
| YIKDIWLGAQRPDTL | 2221 | O60287 | |
| KELESNYRRVWGSPG | 641 | Q13438 | |
| AIRTTVDRPKDWYKT | 86 | O94875 | |
| RADLRGRSPDWYNKV | 981 | Q92502 | |
| LRKQDLEAWGYPVTL | 221 | Q5JTH9 | |
| WVEEKRPLVSSRDYG | 1641 | Q9NRC6 | |
| RSVDWREKGYVTPVK | 116 | P07711 | |
| YSRWRAKGQALPDVV | 56 | O75891 | |
| RTATYLPEVAKEQGW | 251 | Q9Y4X0 | |
| LRLYKEVRSQRPWSG | 1311 | Q96P48 | |
| YLVRRKDPELWGSVL | 946 | Q00610 | |
| RAVAAYRTWSKTIPG | 101 | Q86X52 | |
| RREQKVTSGWGPVKY | 46 | Q7L1S5 | |
| WISQRKPAITYGTRG | 231 | Q96KN2 | |
| PGLREKAEYLLREWV | 1846 | A5YKK6 | |
| LVRYRALSSEWKPEI | 646 | P13591 | |
| NTIPGWLISEDKREY | 2806 | A4UGR9 | |
| PYWADTVKRLLAEGI | 361 | O95985 | |
| SRERKPTGVSVIYWE | 131 | O75467 | |
| EEWGQLKPAQRTLYR | 26 | P52742 | |
| PYVSKVTGWCRDRLL | 221 | Q9BSA9 | |
| DALGKIPQTVLWRYT | 321 | Q9HAW8 | |
| GLLKAEPTRRYRVWS | 151 | Q96NA8 | |
| PWTNKRGEILARYTT | 116 | Q7Z3J2 | |
| KPGYRWERQLVFRSK | 3381 | Q8IZQ1 | |
| AWTIYRPEDSGRRAK | 161 | Q9H171 | |
| FKRFRETVPTWDTIR | 1661 | Q6GYQ0 | |
| AVWAKGIRNVPYRIR | 71 | P62899 | |
| YWKQLLGPRTVEEAI | 396 | Q8N427 | |
| RDKKPIGSSERYQRW | 536 | Q13129 | |
| LFQRRSKLWGDPVES | 1466 | Q9BYB0 | |
| LILKETRRLPWATGY | 66 | Q9ULR3 | |
| RRQTSGPLYLAVWDK | 21 | Q5VYX0 | |
| WEVALYKSVPTRLLS | 106 | Q9UG56 | |
| YKSVPTRLLSRAWGR | 111 | Q9UG56 | |
| SIVGQLYLRWKEPDR | 396 | Q9UM01 | |
| VGIPLRNTERSKDWY | 381 | Q9BX66 | |
| TGWFTLLYEIRLKPE | 161 | P16471 | |
| LGKIPQTVLWRYTGT | 326 | P22309 | |
| EVQTLRPSYWKFLLR | 396 | Q86UB9 | |
| ALGKIPQTVLWRYTG | 326 | P35504 | |
| YSILGVVKRTCWPTD | 726 | Q9HAV4 | |
| YELERTLKGWIPRRL | 126 | Q16560 | |
| KARTLIYRLPGVLTW | 601 | P53804 | |
| DRSLRKVPWYVLAGN | 96 | P13686 | |
| YKGHVNWEILTPIRA | 421 | O60809 | |
| NSTGEPVWKVLIYDR | 36 | Q8WVM8 | |
| LSVTERWKPFLYRGR | 246 | Q9H0V1 | |
| DALGKIPQTVLWRYT | 321 | O60656 | |
| AYVLRGWVDLTSDKP | 146 | Q8NDW8 | |
| LIAWERTKTVQGYRL | 61 | Q9BVS4 | |
| SELSRWIYPDRVKGL | 71 | Q2M218 | |
| RPDVKGRTEILKWYL | 506 | Q96TA2 | |
| VLIQRGYDSDPVKAW | 1076 | P11388 | |
| RYSTLRKIVDIWAGP | 641 | Q96MP5 | |
| IITNLKYWGRCEPIT | 596 | Q9UIA9 | |
| AAGIYVIWGPITERK | 46 | Q70CQ3 | |
| LLVRGIKRVEGRSWY | 446 | Q15650 | |
| GKIPQTVLWRYTGTR | 326 | P19224 | |
| ILAKLSIVPVRRGYW | 156 | P15880 | |
| VKKTPEESWVVFRRY | 131 | P57768 | |
| RKSVTWPEEGKLREY | 396 | Q96QC0 | |
| IARYGILELAWKSLP | 2841 | Q6ZQQ6 | |
| DALGKIPQTVLWRYT | 321 | Q9HAW7 | |
| PLVTRDLKDTWYLIG | 371 | Q6ZMR5 | |
| FIKYWRGELPSVRSK | 196 | Q96MV8 | |
| RSGWKQEIDILRTLY | 941 | P29597 | |
| DALGKIPQTVLWRYT | 321 | Q9HAW9 | |
| ALGKIPQTVLWRYTG | 326 | P22310 | |
| WYKNGVEVRPSKRIT | 471 | Q14324 |